ý | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Massachusetts | 06-0513860 |
(State or other jurisdiction of | (I. R. S. Employer Identification No.) |
incorporation or organization) | |
P.O. Box 188, One Technology Drive, Rogers, Connecticut | 06263-0188 |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer ý | Accelerated filer o | |
Non-accelerated filer o | (Do not check if a smaller reporting company) | Smaller reporting company o |
Emerging growth company o |
TABLE OF CONTENTS | |||
Part I – Financial Information | |||
Part II – Other Information | |||
Item 1. | Financial Statements |
Quarter Ended | |||||||
March 31, 2017 | March 31, 2016 | ||||||
Net sales | $ | 203,828 | $ | 160,566 | |||
Cost of sales | 123,478 | 100,058 | |||||
Gross margin | 80,350 | 60,508 | |||||
Selling, general and administrative expenses | 34,165 | 29,860 | |||||
Research and development expenses | 6,961 | 6,549 | |||||
Restructuring and impairment charges | 725 | — | |||||
Gain on sale of long-lived asset | (942 | ) | — | ||||
Operating income | 39,441 | 24,099 | |||||
Equity income in unconsolidated joint ventures | 1,009 | 613 | |||||
Other income (expense), net | 715 | (546 | ) | ||||
Interest expense, net | (1,248 | ) | (1,121 | ) | |||
Income before income tax expense | 39,917 | 23,045 | |||||
Income tax expense | 12,885 | 8,117 | |||||
Net income | $ | 27,032 | $ | 14,928 | |||
Basic earnings per share | $ | 1.50 | $ | 0.83 | |||
Diluted earnings per share | $ | 1.47 | $ | 0.82 | |||
Shares used in computing: | |||||||
Basic earnings per share | 18,056 | 17,966 | |||||
Diluted earnings per share | 18,373 | 18,214 |
Quarter Ended | |||||||
March 31, 2017 | March 31, 2016 | ||||||
Net income | $ | 27,032 | $ | 14,928 | |||
Foreign currency translation adjustment | 4,138 | 10,926 | |||||
Derivative instruments designated as cash flow hedges: | |||||||
Unrealized gain (loss) on derivative instruments held at period end, net of tax (Note 6) | (114 | ) | 4 | ||||
Unrealized gain (loss) reclassified into earnings (Note 6) | — | 2 | |||||
Pension and postretirement benefit plans reclassified into earnings, net of tax (Note 6): | |||||||
Amortization of loss | 30 | 35 | |||||
Other comprehensive income (loss) | 4,054 | 10,967 | |||||
Comprehensive income (loss) | $ | 31,086 | $ | 25,895 |
March 31, 2017 | December 31, 2016 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 186,111 | $ | 227,767 | |||
Accounts receivable, less allowance for doubtful accounts of $2,336 and $1,952 | 134,084 | 119,604 | |||||
Inventories | 94,795 | 91,130 | |||||
Prepaid income taxes | 3,924 | 3,020 | |||||
Asbestos-related insurance receivables | 7,099 | 7,099 | |||||
Other current assets | 12,616 | 8,910 | |||||
Assets held for sale | 1,727 | 871 | |||||
Total current assets | 440,356 | 458,401 | |||||
Property, plant and equipment, net of accumulated depreciation | 175,642 | 176,916 | |||||
Investments in unconsolidated joint ventures | 16,726 | 16,183 | |||||
Deferred income taxes | 23,480 | 14,634 | |||||
Goodwill | 228,229 | 208,431 | |||||
Other intangible assets | 169,579 | 136,676 | |||||
Asbestos-related insurance receivables | 41,295 | 41,295 | |||||
Other long-term assets | 6,081 | 3,964 | |||||
Total assets | $ | 1,101,388 | $ | 1,056,500 | |||
Liabilities and Shareholders’ Equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 30,297 | $ | 28,379 | |||
Accrued employee benefits and compensation | 24,696 | 31,104 | |||||
Accrued income taxes payable | 15,506 | 10,921 | |||||
Current portion of lease obligation | 356 | 350 | |||||
Current portion of long term debt | — | 3,653 | |||||
Asbestos-related liabilities | 7,099 | 7,099 | |||||
Other accrued liabilities | 19,162 | 19,679 | |||||
Total current liabilities | 97,116 | 101,185 | |||||
Borrowings under credit facility | 241,188 | 235,877 | |||||
Long term lease obligation | 4,962 | 4,993 | |||||
Pension and post-retirement benefit obligations | 8,501 | 8,501 | |||||
Retiree health care and life insurance benefits | 1,992 | 1,992 | |||||
Asbestos-related liabilities | 44,883 | 44,883 | |||||
Non-current income tax | 6,517 | 6,238 | |||||
Deferred income taxes | 13,463 | 13,883 | |||||
Other long-term liabilities | 3,527 | 3,162 | |||||
Commitments and Contingencies (Note 14) | |||||||
Shareholders’ Equity | |||||||
Capital Stock - $1 par value; 50,000 authorized shares; 18,121 and 18,021 shares outstanding | 18,121 | 18,021 | |||||
Additional paid-in capital | 118,213 | 118,678 | |||||
Retained earnings | 631,113 | 591,349 | |||||
Accumulated other comprehensive income (loss) | (88,208 | ) | (92,262 | ) | |||
Total shareholders’ equity | 679,239 | 635,786 | |||||
Total liabilities and shareholders’ equity | $ | 1,101,388 | $ | 1,056,500 |
Three Months Ended | |||||||
March 31, 2017 | March 31, 2016 | ||||||
Operating Activities: | |||||||
Net income | $ | 27,032 | $ | 14,928 | |||
Adjustments to reconcile net income to cash from operating activities: | |||||||
Depreciation and amortization | 10,547 | 8,973 | |||||
Stock-based compensation expense | 1,020 | 1,992 | |||||
Deferred income taxes | 3,516 | 1,013 | |||||
Equity in undistributed income of unconsolidated joint ventures | (1,009 | ) | (613 | ) | |||
Dividends received from unconsolidated joint ventures | 616 | — | |||||
Pension and postretirement benefits | (365 | ) | (702 | ) | |||
Loss (gain) from the sale of property, plant and equipment | (947 | ) | — | ||||
Bad debt expense | 384 | — | |||||
Proceeds from insurance related to operations | 480 | — | |||||
Changes in operating assets and liabilities, excluding effects of acquisitions: | |||||||
Accounts receivable | (12,439 | ) | (6,657 | ) | |||
Inventories | (769 | ) | (1,021 | ) | |||
Pension contribution | (70 | ) | (63 | ) | |||
Other current assets | (4,063 | ) | (1,621 | ) | |||
Accounts payable and other accrued expenses | (1,441 | ) | 8,307 | ||||
Other, net | 742 | 1,651 | |||||
Net cash provided by operating activities | 23,234 | 26,187 | |||||
Investing Activities: | |||||||
Business acquisition | (60,191 | ) | — | ||||
Capital expenditures, net | (5,270 | ) | (4,813 | ) | |||
Proceeds from insurance related to property, plant and equipment | 450 | — | |||||
Proceeds from the sale of property, plant and equipment, net | 1,603 | — | |||||
Net cash used in investing activities | (63,408 | ) | (4,813 | ) | |||
Financing Activities: | |||||||
Proceeds from long term borrowings | — | — | |||||
Debt issuance costs | (1,029 | ) | — | ||||
Repayment of debt principal and long term lease obligation | (87 | ) | (757 | ) | |||
Repurchases of capital stock | — | (1,997 | ) | ||||
Proceeds from the exercise of stock options, net | 765 | 564 | |||||
Issuance of shares upon vesting of restricted stock units, net | (2,572 | ) | (1,175 | ) | |||
Proceeds from issuance of shares to employee stock purchase plan | 422 | 427 | |||||
Net cash (used in) provided by financing activities | (2,501 | ) | (2,938 | ) | |||
Effect of exchange rate fluctuations on cash | 1,019 | 6,181 | |||||
Net increase (decrease) in cash and cash equivalents | (41,656 | ) | 24,617 | ||||
Cash and cash equivalents at beginning of period | 227,767 | 204,586 | |||||
Cash and cash equivalents at end of period | $ | 186,111 | $ | 229,203 |
Capital Stock/Capital Shares | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders’ Equity | |||||||||||||||
Balance at December 31, 2016 | $ | 18,021 | $ | 118,678 | $ | 591,349 | $ | (92,262 | ) | $ | 635,786 | ||||||||
Net income | — | — | 27,032 | — | 27,032 | ||||||||||||||
Other comprehensive income (loss) | — | — | — | 4,054 | 4,054 | ||||||||||||||
Stock options exercised | 22 | 743 | — | — | 765 | ||||||||||||||
Shares issued for employees stock purchase plan | 8 | 414 | — | — | 422 | ||||||||||||||
Shares issued for vested restricted stock units, net of cancellations for tax withholding | 70 | (2,642 | ) | — | — | (2,572 | ) | ||||||||||||
Cumulative-effect adjustment of change in accounting for share-based compensation | — | — | 12,732 | — | 12,732 | ||||||||||||||
Stock-based compensation expense | — | 1,020 | — | — | 1,020 | ||||||||||||||
Balance at March 31, 2017 | $ | 18,121 | $ | 118,213 | $ | 631,113 | $ | (88,208 | ) | $ | 679,239 |
• | Level 1 – Quoted prices in active markets for identical assets or liabilities. |
• | Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. |
(Dollars in thousands) | Carrying amount as of March 31, 2017 | Level 1 | Level 2 | Level 3 | ||||||||||||
Foreign currency contracts | $ | 21 | $ | — | $ | 21 | $ | — | ||||||||
Copper derivative contracts | $ | 1,342 | $ | — | $ | 1,342 | $ | — | ||||||||
Interest rate swap | $ | (180 | ) | $ | — | $ | (180 | ) | $ | — |
(Dollars in thousands) | Carrying amount as of December 31, 2016 | Level 1 | Level 2 | Level 3 | ||||||||||||
Foreign currency contracts | $ | (170 | ) | $ | — | $ | (170 | ) | $ | — | ||||||
Copper derivative contracts | $ | 1,277 | $ | — | $ | 1,277 | $ | — |
• | Foreign Currency - The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics. |
• | Commodity - The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates the constant changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date. Overall, fair value is a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate, and volatility. |
• | Interest Rates - The fair value of interest rate swap instruments is derived by comparing the present value of the interest rate forward curve against the present value of the swap rate, relative to the notional amount of the swap. The net value represents the estimated amount we would receive or pay to terminate the agreements. Settlement amounts for an “in the money” swap would be adjusted down to compensate the counterparty for cost of funds, and the adjustment is directly related to the counterparties’ credit ratings. |
Notional Values of Foreign Currency Derivatives | ||||
KRW/USD | ₩ | 5,291,766,000 | ||
USD/JPY | $ | 512,637 | ||
JPY/EUR | ¥ | 338,000,000 | ||
EUR/USD | € | 3,914,930 | ||
EUR/HUF | € | 586,678 | ||
USD/CNY | $ | 6,083,500 |
Notional Value of Copper Derivatives | ||
April 2017 - June 2017 | 122 | metric tons per month |
July 2017 - September 2017 | 122 | metric tons per month |
October 2017 - December 2017 | 122 | metric tons per month |
January 2018 - March 2018 | 56 | metric tons per month |
April 2018 - June 2018 | 25 | metric tons per month |
(Dollars in thousands) | The Effect of Current Derivative Instruments on the Financial Statements for the period ended March 31, 2017 | Fair Values of Derivative Instruments as of March 31, 2017 | |||||||
Gain (Loss) | Other Assets (Liabilities) | ||||||||
Foreign Exchange Contracts | Location | ||||||||
Contracts not designated as hedging instruments | Other income (expense), net | $ | 21 | $ | 21 | ||||
Copper Derivatives | |||||||||
Contracts not designated as hedging instruments | Other income (expense), net | $ | 215 | $ | 1,342 | ||||
Interest Rate Swap | |||||||||
Contract designated as hedging instrument | Other comprehensive income (loss) | $ | (180 | ) | $ | (180 | ) |
(Dollars in thousands) | The Effect of Current Derivative Instruments on the Financial Statements for the period ended March 31, 2016 | Fair Values of Derivative Instruments as of March 31, 2016 | |||||||
Gain (Loss) | Other Assets (Liabilities) | ||||||||
Foreign Exchange Contracts | Location | ||||||||
Contracts not designated as hedging instruments | Other income (expense), net | $ | (114 | ) | $ | (114 | ) | ||
Copper Derivatives | |||||||||
Contracts not designated as hedging instruments | Other income (expense), net | $ | 33 | $ | 255 | ||||
Interest Rate Swap | |||||||||
Contracts designated as hedging instruments | Other comprehensive income (loss) | $ | 11 | $ | (7 | ) |
(Dollars in thousands) | March 31, 2017 | December 31, 2016 | |||||
Raw materials | $ | 33,850 | $ | 29,788 | |||
Work-in-process | 26,452 | 26,440 | |||||
Finished goods | 34,493 | 34,902 | |||||
Total inventories | $ | 94,795 | $ | 91,130 |
(Dollars in thousands) | January 6, 2017 | ||
Assets: | |||
Accounts receivable | $ | 2,724 | |
Prepaid expenses | 21 | ||
Inventory | 2,433 | ||
Property, plant & equipment | 1,589 | ||
Intangible assets | 35,860 | ||
Goodwill | 17,793 | ||
Total assets | 60,420 | ||
Liabilities: | |||
Accounts payable | 179 | ||
Accrued expenses | 50 | ||
Total liabilities | 229 | ||
Fair value of net assets acquired | $ | 60,191 |
(Dollars in thousands) | November 23, 2016 | ||
Assets: | |||
Cash and cash equivalents | $ | 1,539 | |
Accounts receivable | 7,513 | ||
Other current assets | 691 | ||
Inventory | 9,915 | ||
Property, plant & equipment | 9,932 | ||
Intangible assets | 73,500 | ||
Goodwill | 35,755 | ||
Other long-term assets | 101 | ||
Total assets | 138,946 | ||
Liabilities: | |||
Accounts payable | 2,402 | ||
Other current liabilities | 1,062 | ||
Total liabilities | 3,464 | ||
Fair value of net assets acquired | $ | 135,482 |
(Dollars in thousands) | Three months ended March 31, 2016 | ||
Net sales | $ | 178,897 | |
Net income | 13,263 |
(Dollars in thousands) | Foreign currency translation adjustments | Funded status of pension plans and other postretirement benefits (1) | Unrealized gain (loss) on derivative instruments (2) | Total | |||||||||||
Beginning Balance December 31, 2015 | $ | (41,365 | ) | $ | (47,082 | ) | $ | (11 | ) | $ | (88,458 | ) | |||
Other comprehensive income (loss) before reclassifications | 10,926 | — | 4 | 10,930 | |||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) (3) | — | 35 | 2 | 37 | |||||||||||
Net current-period other comprehensive income (loss) | 10,926 | 35 | 6 | 10,967 | |||||||||||
Ending Balance March 31, 2016 | $ | (30,439 | ) | $ | (47,047 | ) | $ | (5 | ) | $ | (77,491 | ) | |||
Beginning Balance December 31, 2016 | $ | (46,446 | ) | $ | (45,816 | ) | $ | — | $ | (92,262 | ) | ||||
Other comprehensive income (loss) before reclassifications | 4,138 | — | (114 | ) | 4,024 | ||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) (4) | — | 30 | — | 30 | |||||||||||
Net current-period other comprehensive income (loss) | 4,138 | 30 | (114 | ) | 4,054 | ||||||||||
Ending Balance March 31, 2017 | $ | (42,308 | ) | $ | (45,786 | ) | $ | (114 | ) | $ | (88,208 | ) |
(In thousands, except per share amounts) | Quarter Ended | ||||||
March 31, 2017 | March 31, 2016 | ||||||
Numerator: | |||||||
Net income | $ | 27,032 | $ | 14,928 | |||
Denominator: | |||||||
Weighted-average shares outstanding - basic | 18,056 | 17,966 | |||||
Effect of dilutive shares | 317 | 248 | |||||
Weighted-average shares outstanding - diluted | 18,373 | 18,214 | |||||
Basic earnings per share | $ | 1.50 | $ | 0.83 | |||
Diluted earnings per share | $ | 1.47 | $ | 0.82 |
March 31, 2017 | March 31, 2016 | |||
Expected volatility | 33.6% | 29.6% | ||
Expected term (in years) | 3.0 | 3.0 | ||
Risk-free interest rate | 1.38% | 0.93% |
Performance-Based Restricted Stock Awards | ||
Non-vested awards outstanding at December 31, 2016 | 151,769 | |
Awards granted | 56,147 | |
Stock issued | (33,887 | ) |
Awards forfeited | (3,205 | ) |
Non-vested awards outstanding at March 31, 2017 | 170,824 |
Time-Based Restricted Stock Awards | ||
Non-vested awards outstanding at December 31, 2016 | 239,189 | |
Awards granted | 75,710 | |
Stock issued | (67,183 | ) |
Awards forfeited | (4,385 | ) |
Non-vested awards outstanding at March 31, 2017 | 243,331 |
Deferred Stock Units | ||
Awards outstanding at December 31, 2016 | 11,900 | |
Awards granted | — | |
Stock issued | — | |
Awards outstanding at March 31, 2017 | 11,900 |
Options Outstanding | Weighted- Average Exercise Price Per Share | Weighted-Average Remaining Contractual Life in Years | Aggregate Intrinsic Value | |||||||||
Options outstanding at December 31, 2016 | 116,575 | $ | 37.76 | 3.2 | $ | 4,552,580 | ||||||
Options exercised | (22,300 | ) | $ | 34.30 | ||||||||
Options forfeited | — | $ | — | |||||||||
Options outstanding at March 31, 2017 | 94,275 | $ | 37.46 | 3.1 | $ | 4,563,655 | ||||||
Options exercisable at March 31, 2017 | 94,275 | $ | 37.46 | 3.1 | $ | 4,563,655 | ||||||
Options vested at March 31, 2017 | 94,275 | $ | 37.46 | 3.1 | $ | 4,563,655 |
(Dollars in thousands) | Pension Benefits | Retirement Health and Life Insurance Benefits | |||||||||||||
Quarter Ended | Quarter Ended | ||||||||||||||
Change in benefit obligation: | March 31, 2017 | March 31, 2016 | March 31, 2017 | March 31, 2016 | |||||||||||
Service cost | $ | — | $ | — | $ | 39 | $ | 37 | |||||||
Interest cost | 1,841 | 1,893 | 18 | 19 | |||||||||||
Expected return on plan assets | (2,309 | ) | (2,706 | ) | — | — | |||||||||
Amortization of prior service cost (credit) | — | — | (373 | ) | (373 | ) | |||||||||
Amortization of net loss (gain) | 433 | 447 | (14 | ) | (19 | ) | |||||||||
Net periodic (benefit) cost | $ | (35 | ) | $ | (366 | ) | $ | (330 | ) | $ | (336 | ) |
Quarter Ended | |||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | |||||
Net sales | |||||||
Advanced Connectivity Solutions | $ | 78,543 | $ | 73,376 | |||
Elastomeric Material Solutions | 76,849 | 46,317 | |||||
Power Electronics Solutions | 42,651 | 35,251 | |||||
Other | 5,785 | 5,622 | |||||
Net sales | $ | 203,828 | $ | 160,566 | |||
Operating income | |||||||
Advanced Connectivity Solutions | $ | 19,689 | $ | 15,900 | |||
Elastomeric Material Solutions | 12,912 | 5,305 | |||||
Power Electronics Solutions | 4,935 | 1,296 | |||||
Other | 1,905 | 1,598 | |||||
Operating income | 39,441 | 24,099 | |||||
Equity income in unconsolidated joint ventures | 1,009 | 613 | |||||
Other income (expense), net | 715 | (546 | ) | ||||
Interest expense, net | (1,248 | ) | (1,121 | ) | |||
Income before income tax expense | $ | 39,917 | $ | 23,045 |
Joint Venture | Location | Reportable Segment | Fiscal Year-End |
Rogers INOAC Corporation (RIC) | Japan | Elastomeric Material Solutions | October 31 |
Rogers INOAC Suzhou Corporation (RIS) | China | Elastomeric Material Solutions | December 31 |
Quarter Ended | |||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | |||||
Net sales | $ | 11,185 | $ | 9,237 | |||
Gross profit | $ | 4,311 | $ | 3,099 | |||
Net income | $ | 2,018 | $ | 1,226 |
(Dollars in thousands) | Advanced Connectivity Solutions | Elastomeric Material Solutions | Power Electronics Solutions | Other | Total | ||||||||||||||
December 31, 2016 | $ | 51,693 | $ | 91,531 | $ | 62,983 | $ | 2,224 | $ | 208,431 | |||||||||
Foreign currency translation adjustment | — | 1,143 | 746 | — | 1,889 | ||||||||||||||
Purchase accounting adjustment | — | 116 | — | — | 116 | ||||||||||||||
DSP acquisition | — | 17,793 | — | — | 17,793 | ||||||||||||||
March 31, 2017 | $ | 51,693 | $ | 110,583 | $ | 63,729 | $ | 2,224 | $ | 228,229 |
March 31, 2017 | December 31, 2016 | ||||||||||||||||||||||
(Dollars in thousands) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||
Trademarks and patents | $ | 10,177 | $ | 1,401 | $ | 8,776 | $ | 6,825 | $ | 1,156 | $ | 5,669 | |||||||||||
Technology | 71,086 | 26,217 | 44,869 | 68,880 | 24,365 | 44,515 | |||||||||||||||||
Covenant not to compete | 1,751 | 1,009 | 742 | 1,419 | 932 | 487 | |||||||||||||||||
Customer relationships | 127,102 | 16,127 | 110,975 | 96,148 | 14,311 | 81,837 | |||||||||||||||||
Total definite lived intangible assets | 210,116 | 44,754 | 165,362 | 173,272 | 40,764 | 132,508 | |||||||||||||||||
Indefinite lived intangible assets | 4,217 | — | 4,217 | 4,168 | — | 4,168 | |||||||||||||||||
Total intangible assets | $ | 214,333 | $ | 44,754 | $ | 169,579 | $ | 177,440 | $ | 40,764 | $ | 136,676 |
Intangible Asset Class | Weighted Average Amortization Period (Years) | |
Trademarks and patents | 7.0 | |
Technology | 5.8 | |
Customer relationships | 10.1 | |
Covenant not to compete | 3.3 | |
Total definite lived intangible assets | 8.8 |
Asbestos Claims Activity | ||
Claims outstanding at December 31, 2016 | 605 | |
New claims filed | 110 | |
Pending claims concluded | (123 | ) |
Claims outstanding at March 31, 2017 | 592 |
(Dollars in thousands) | Severance related to headquarters relocation | ||
Balance at December 31, 2016 | $ | 470 | |
Provisions | 193 | ||
Payments | (238 | ) | |
Balance at March 31, 2017 | $ | 425 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | failure to capitalize on, or volatility within, the Company’s growth drivers, including connectivity, clean energy, and safety and protection; |
• | uncertain business, economic and political conditions in the United States and abroad, particularly in China, South Korea, Germany, Hungary and Belgium, where we maintain significant manufacturing, sales or administrative operations; |
• | fluctuations in foreign currency exchange rates; |
• | our ability to develop innovative products and have them incorporated into end-user products and systems; |
• | the extent to which end-user products and systems incorporating our products achieve commercial success; |
• | the ability of our sole or limited source suppliers to deliver certain key raw materials to us in a timely manner; |
• | intense global competition affecting both our existing products and products currently under development; |
• | failure to realize, or delays in the realization of, anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses; |
• | our ability to attract and retain management and skilled technical personnel; |
• | our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third party rights; |
• | changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate; |
• | failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants; |
• | the outcome of ongoing and future litigation, including our asbestos-related product liability litigation; |
• | changes in environmental laws and regulations applicable to our business; |
• | disruptions in, or breaches of, our information technology systems; |
• | asset impairment and restructuring charges; and |
• | changes in accounting standards promulgated by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC). |
• | Our net sales increase in the first quarter of 2017 was attributable to increases in net sales of all three of our segments, ACS, EMS and PES. The EMS segment net sales increased 49.1% due to the DeWAL and DSP acquisitions that occurred in the fourth quarter of 2016 and the first quarter of 2017, respectively, and 16.8% due to increased EMS organic net sales as a result of higher demand in portable electronics, general industrial, automotive and mass transit applications. ACS segment net sales increased on higher demand in automotive and aerospace and defense, partially offset by softening demand in wireless 4G LTE applications. PES saw higher demand for renewable energy, hybrid electric vehicles, variable frequency motor drives, and laser diode coolers. Net sales in the first quarter of 2017 in each of our strategic business segments were negatively impacted by currency fluctuations. See “Segment Sales and Operations.” |
• | Our gross margin improved 170 basis points and our operating margin improved 440 basis points in the first quarter of 2017. Our gross margin improved to 39.4% in the first quarter of 2017 as compared to 37.7% in the first quarter of 2016. Operating income increased to $39.4 million in the first quarter of 2017, as compared to $24.1 million in the first quarter of 2016. Our margins increased as a result of increased demand, capacity utilization, operational process enhancements and automation, conversion of fixed cost structure to variable, benefits from low cost country manufacturing expansion, and synergies from the recent acquisitions. |
• | We acquired DeWAL (in late 2016) and DSP (in early 2017), as we continue to execute on our synergistic acquisition strategy. Acquisitions are a core part of our growth strategy, and these particular acquisitions extend the product portfolio and technology capabilities of our EMS segment, with complementary high-end, high performance elastomeric materials. |
• | We are an innovation company, and in the first quarter of 2017 we continued our investment in research and development, with research and development expenses 3.4% of our quarterly net sales. Research and development (R&D) expenses were $7.0 million in the first quarter of 2017, which is an increase of $0.5 million from the first quarter of 2016. Our spending continues to be focused on developing new platforms and technologies. Since 2013, we have made concerted efforts to realign our R&D organization to better fit the future direction of the Company, including dedicating resources to focus on current product extensions and enhancements to meet our short term technology needs. |
Quarter Ended | |||||
March 31, 2017 | March 31, 2016 | ||||
Net sales | 100.0 | % | 100.0 | % | |
Gross margin | 39.4 | % | 37.7 | % | |
Selling, general and administrative expenses | 16.8 | % | 18.6 | % | |
Research and development expenses | 3.4 | % | 4.1 | % | |
Restructuring and impairment charges | 0.4 | % | — | % | |
Gain on sale of long-lived asset | (0.5 | )% | — | % | |
Operating income | 19.4 | % | 15.0 | % | |
Equity income in unconsolidated joint ventures | 0.5 | % | 0.4 | % | |
Other income (expense), net | 0.4 | % | (0.3 | )% | |
Interest expense, net | (0.6 | )% | (0.7 | )% | |
Income before income tax expense | 19.6 | % | 14.4 | % | |
Income tax expense | 6.3 | % | 5.1 | % | |
Net income | 13.3 | % | 9.3 | % |
Net Sales | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Net sales | $ | 203,828 | $ | 160,566 | 26.9% | |||||
Gross margin | 39.4 | % | 37.7 | % |
Selling, General and Administrative Expenses | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Selling, general and administrative expenses | $ | 34,165 | $ | 29,860 | 14.4% | |||||
Percentage of sales | 16.8 | % | 18.6 | % |
Research and Development Expenses | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Research and development expenses | $ | 6,961 | $ | 6,549 | 6.3% | |||||
Percentage of sales | 3.4 | % | 4.1 | % |
Other operating expenses (income) | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Restructuring and impairment charges | $ | 725 | $ | — | 100.0% | |||||
Gain on sale of long-lived asset | (942 | ) | — | 100.0% |
Equity Income in Unconsolidated Joint Ventures | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Equity income in unconsolidated joint ventures | $ | 1,009 | $ | 613 | 64.6% |
Other Income (Expense), Net | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Other income (expense), net | $ | 715 | $ | (546 | ) | 231.0% |
Interest Expense, Net | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Interest expense, net | $ | (1,248 | ) | $ | (1,121 | ) | 11.3% |
Income Taxes | Quarter Ended | |||||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | Percent Change | |||||||
Income tax expense | $ | 12,885 | $ | 8,117 | 58.7% | |||||
Effective tax rate | 32.3 | % | 35.2 | % |
Quarter Ended | |||||||
(Dollars in millions) | March 31, 2017 | March 31, 2016 | |||||
Net sales | $ | 78.5 | $ | 73.4 | |||
Operating income | $ | 19.7 | $ | 15.9 |
Quarter Ended | |||||||
(Dollars in millions) | March 31, 2017 | March 31, 2016 | |||||
Net sales | $ | 76.8 | $ | 46.3 | |||
Operating income | $ | 12.9 | $ | 5.3 |
Quarter Ended | |||||||
(Dollars in millions) | March 31, 2017 | March 31, 2016 | |||||
Net sales | $ | 42.7 | $ | 35.3 | |||
Operating income | $ | 4.9 | $ | 1.3 |
Quarter Ended | |||||||
(Dollars in millions) | March 31, 2017 | March 31, 2016 | |||||
Net sales | $ | 5.8 | $ | 5.6 | |||
Operating income | $ | 1.9 | $ | 1.6 |
(Dollars in thousands) | March 31, 2017 | December 31, 2016 | |||||
Key Balance Sheet Accounts: | |||||||
Cash and cash equivalents | $ | 186,111 | $ | 227,767 | |||
Accounts receivable, net | $ | 134,084 | $ | 119,604 | |||
Inventories | $ | 94,795 | $ | 91,130 | |||
Outstanding borrowing on credit facilities (short term and long term) | $ | 241,188 | $ | 241,188 |
Three Months Ended | |||||||
(Dollars in thousands) | March 31, 2017 | March 31, 2016 | |||||
Key Cash Flow Measures: | |||||||
Cash provided by operating activities | $ | 23,234 | $ | 26,187 | |||
Cash used in investing activities | $ | (63,408 | ) | $ | (4,813 | ) | |
Cash (used in) provided by financing activities | $ | (2,501 | ) | $ | (2,938 | ) |
(Dollars in thousands) | March 31, 2017 | December 31, 2016 | |||||
U.S. | $ | 37,868 | $ | 95,481 | |||
Europe | 43,897 | 37,791 | |||||
Asia | 104,346 | 94,495 | |||||
Total cash and cash equivalents | $ | 186,111 | $ | 227,767 |
◦ | Accounts receivable increased 12.1% to $134.1 million as of March 31, 2017, from $119.6 million at December 31, 2016. The increase from year end was primarily due to higher net sales in the first quarter of 2017, in comparison with the fourth quarter of 2016 due to higher net sales in all of our operating segments. Additionally, accounts receivable increased $2.8 million due to the acquisition of DSP in January 2017. |
◦ | Deferred income tax assets increased 60.4% to $23.5 million as of March 31, 2017, from $14.6 million at December 31, 2016. The increase is due to the recognition of $12.7 million in deferred tax assets previously not recognized in accordance with the adoption of new accounting guidance. |
◦ | Goodwill increased 9.5% to $228.2 million as of March 31, 2017, from $208.4 million at December 31, 2016. the increase is primarily due to the acquisition of DSP in January 2017. |
◦ | Other intangible assets increased 24.1% to $169.6 million as of March 31, 2017, from $136.7 million at December 31, 2016. This overall increase is due to the acquisition of DSP in January 2017. |
◦ | Accrued employee benefits and compensation decreased 20.6% to $24.7 million as of March 31, 2017, from $31.1 million at December 31, 2016. This is primarily due to incentive compensation payouts of $9.0 million that occurred in the first quarter of 2017, partially offset by $3.2 million of accruals for projected incentive compensation payouts for the current performance year. |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
Item 4. | Controls and Procedures |
Item 1. | Legal Proceedings |
List of Exhibits: | |
3.1 | Restated Articles of Organization of Rogers Corporation, as amended, incorporated by reference to Exhibit 3a to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006 (the 2006 Form 10-K) (File No. 001-04347). |
3.2 | Amended and Restated Bylaws of Rogers Corporation, effective February 11, 2016, incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on February 26, 2016. |
10.1 | Third Amended and Restated Credit Agreement, dated as of February 17, 2017 among Rogers Corporation, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, HSBC Bank USA, National Association and Citizens Bank, N.A. as co-syndication agents, and Citibank, N.A. as documentation agent, incorporated by reference to Exhibit 10.24 to the Registrant’s Annual Report on Form 10-K filed February 21, 2017. |
31.1 | Certification of President and Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. |
31.2 | Certification of Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. |
32 | Certification of President and Chief Executive Officer (Principal Executive Officer) and Vice President, Finance and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith. |
101 | The following materials from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2017 formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended March 31, 2017 and March 31, 2016, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2017 and March 31, 2016, (iii) Condensed Consolidated Statements of Financial Position at March 31, 2017 and December 31, 2016, (iv) Condensed Consolidated Statement of Shareholders’ Equity at March 31, 2017 and December 31, 2016, (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2017 and March 31, 2016 and (vi) Notes to Condensed Consolidated Financial Statements. |
ROGERS CORPORATION (Registrant) |
/s/ Janice E. Stipp | ||
Janice E. Stipp Senior Vice President, Finance and Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | ||
Dated: May 1, 2017 |
1. | I have reviewed this quarterly report on Form 10-Q of Rogers Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: May 1, 2017 |
/s/ Bruce D. Hoechner |
Bruce D. Hoechner |
President and Chief Executive Officer, |
Principal Executive Officer |
1. | I have reviewed this quarterly report on Form 10-Q of Rogers Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: May 1, 2017 |
/s/ Janice E. Stipp |
Janice E. Stipp |
Senior Vice President, Finance and Chief Financial Officer, |
Principal Financial Officer and Principal Accounting Officer |
/s/ Bruce D. Hoechner |
Bruce D. Hoechner |
President and Chief Executive Officer, |
Principal Executive Officer |
May 1, 2017 |
/s/ Janice E. Stipp |
Janice E. Stipp |
Senior Vice President, Finance and Chief Financial Officer, |
Principal Financial Officer and Principal Accounting Officer |
May 1, 2017 |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Apr. 24, 2017 |
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | ROGERS CORP | |
Trading Symbol | ROG | |
Entity Central Index Key | 0000084748 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 18,126,756 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Income Statement [Abstract] | ||
Net sales | $ 203,828 | $ 160,566 |
Cost of sales | 123,478 | 100,058 |
Gross margin | 80,350 | 60,508 |
Selling, general and administrative expenses | 34,165 | 29,860 |
Research and development expenses | 6,961 | 6,549 |
Restructuring and impairment charges | 725 | 0 |
Gain on sale of long-lived asset | (942) | 0 |
Operating income | 39,441 | 24,099 |
Equity income in unconsolidated joint ventures | 1,009 | 613 |
Other income (expense), net | 715 | (546) |
Interest expense, net | (1,248) | (1,121) |
Income before income tax expense | 39,917 | 23,045 |
Income tax expense | 12,885 | 8,117 |
Net income | $ 27,032 | $ 14,928 |
Basic earnings per share (in dollars per share) | $ 1.50 | $ 0.83 |
Diluted earnings per share (in dollars per share) | $ 1.47 | $ 0.82 |
Shares used in computing: | ||
Basic earnings per share (shares) | 18,056 | 17,966 |
Diluted earnings per share (shares) | 18,373 | 18,214 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 27,032 | $ 14,928 |
Foreign currency translation adjustment | 4,138 | 10,926 |
Derivative instruments designated as cash flow hedges: | ||
Unrealized gain (loss) on derivative instruments held at period end, net of tax (Note 6) | (114) | 4 |
Unrealized gain (loss) reclassified into earnings (Note 6) | 0 | 2 |
Pension and postretirement benefit plans reclassified into earnings, net of tax (Note 6): | ||
Amortization of loss | 30 | 35 |
Other comprehensive income (loss) | 4,054 | 10,967 |
Comprehensive income (loss) | $ 31,086 | $ 25,895 |
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts | $ 2,336 | $ 1,952 |
Capital Stock, par value (in dollars per share) | $ 1 | $ 1 |
Capital Stock, authorized shares (shares) | 50,000,000 | 50,000,000 |
Capital Stock, shares outstanding (shares) | 18,121,000 | 18,021,000 |
Basis of Presentation |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its subsidiaries, unless the context indicates otherwise. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for their fair presentation in accordance with GAAP. All significant intercompany transactions have been eliminated. Certain statement of financial position reclassifications have been made to prior period balances in order to conform to the current period’s presentation. Interim results are not necessarily indicative of results for a full year. For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. |
Fair Value Measurements |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements | Fair Value Measurements The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:
From time to time we enter into various instruments that require fair value measurement. Assets and liabilities measured on a recurring basis, categorized by the level of inputs used in the valuation, included:
|
Hedging Transactions and Derivative Financial Instruments |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hedging Transactions and Derivative Financial Instruments | Hedging Transactions and Derivative Financial Instruments We are exposed to certain risks related to our ongoing business operations. The primary risks being managed through our use of derivative instruments are foreign currency exchange rate risk and commodity pricing risk (primarily related to copper). During the first quarter of 2017, we also entered into an interest rate swap to hedge interest rate risk. We do not use derivative financial instruments for trading or speculative purposes. The valuation of derivative contracts used to manage each of these risks is described below:
The guidance for the accounting and disclosure of derivatives and hedging transactions requires companies to recognize all of their derivative instruments as either assets or liabilities at fair value in the statements of financial position. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies for hedge accounting treatment as defined under the applicable accounting guidance. For derivative instruments that are designated and qualify for hedge accounting treatment (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss). This gain or loss is reclassified into earnings in the same line item of the condensed consolidated statements of operations associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of the future cash flows of the hedged item (i.e., the ineffective portion) if any, is recognized in the condensed consolidated statements of operations during the current period. As of March 31, 2017 only our interest rate swap qualified for hedge accounting treatment. For the three months ended March 31, 2017 and 2016 there was no hedge ineffectiveness. Foreign Currency During the quarter ended March 31, 2017, we entered into Chinese Yuan, Japanese Yen, and Korean Won forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations. As of March 31, 2017 the notional values of these foreign currency forward contracts were:
Commodity We currently have twenty-four outstanding contracts to hedge exposure related to the purchase of copper in our Power Electronics Solutions (PES) and Advanced Connectivity Solutions (ACS) operations. These contracts are held with financial institutions and minimize the risk associated with a potential rise in copper prices. These contracts provide some coverage over the forecasted 2017 monthly copper exposure and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations. The notional values of our copper contracts outstanding as of March 31, 2017 were:
Interest Rates In March 2017, we entered into an interest rate swap to hedge the variable interest rate on $75.0 million of our $450.0 million revolving credit facility. This transaction has been designated as a cash flow hedge and qualifies for hedge accounting treatment. See Note 12, “Debt” for further discussion regarding the credit facility. In July 2012, we entered into an interest rate swap to hedge the variable interest rate on our previously outstanding term loan debt. This swap expired as of June 30, 2016. Effects on Statements of Operations and of Comprehensive Income (Loss):
|
Inventories |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | Inventories Inventories are valued at the lower of cost or market. Inventories were as follows at the end of the periods noted below:
|
Acquisitions |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions | Acquisitions Diversified Silicone Products On January 6, 2017, we acquired the principal operating assets of Diversified Silicone Products, Inc. (“DSP”), pursuant to the terms of the Asset Purchase Agreement by and among the Company, DSP and the principal shareholders of DSP (the “Purchase Agreement”). Pursuant to the terms of the Purchase Agreement, we acquired certain assets and assumed certain liabilities of DSP for a total purchase price of approximately $60.2 million. We used borrowings of $30.0 million under our credit facility in addition to cash on hand to fund the acquisition. DSP is a custom silicone product development and manufacturing business and expands the portfolio of Rogers’ Elastomeric Material Solutions business (“EMS”) in cellular sponge and specialty extruded silicone profile technologies, while strengthening existing expertise in precision-calendered silicone and silicone formulating and compounding. The acquisition has been accounted for in accordance with applicable purchase accounting guidance. On a preliminary basis, we recorded goodwill primarily related to the expected synergies from combining operations and the value of the existing workforce. We also recorded intangible assets related to acquired customer relationships, developed technology, trademarks, and a covenant not to compete. As of the filing date of this Form 10-Q, the final purchase accounting and purchase price allocation for the DSP acquisition are substantially complete, however, we continue to refine our preliminary valuation of certain acquired assets. Goodwill is subject to change based on the finalization of acquisition accounting. The following table represents the preliminary fair market values assigned to the acquired assets and liabilities in the transaction:
The intangible assets consists of customer relationships valued at $30.5 million, developed technology valued at $1.8 million, trademarks valued at $3.3 million, and a covenant to not compete valued at $0.3 million. The fair value of acquired identified intangible assets was determined by applying the income approach, using several significant unobservable inputs for projected cash flows and a discount rate. These inputs are considered Level 3 under the fair value measurements and disclosure guidance. The weighted average amortization period for the intangible asset classes are 11.8 years for customer relationships, 4.3 years for developed technology, 11.7 years for trademarks, and 4.1 years for a covenant not to compete, resulting in amortization expenses ranging from $1.1 million to $2.0 million annually. The estimated annual future amortization expense is $1.5 million for the remainder of 2017, $1.9 million for 2018, and $1.8 million for 2019, 2020, and 2021. During the first quarter of 2017, we incurred transaction costs of $0.5 million, which were recorded within selling, general and administrative expenses on the condensed consolidated statements of operations. The results of DSP have been included in our condensed consolidated financial statements only for the period subsequent to the completion of the acquisition on January 6, 2017, through March 31, 2017. DSP’s net sales for this period totaled $5.5 million. DeWAL On November 23, 2016, we acquired all of the membership interests in DeWAL Industries LLC (“DeWAL”), pursuant to the terms of the Membership Interest Purchase Agreement, dated November 23, 2016, by and among the Company and the owners of DeWAL for an aggregate purchase price of $135.5 million. We used borrowings of $136.0 million under our credit facility to fund the acquisition. DeWAL is a leading manufacturer of polytetrafluoroethylene and ultra-high molecular weight polyethylene films, pressure sensitive tapes and specialty products for the industrial, aerospace, automotive, and electronics markets. The acquisition has been accounted for in accordance with applicable purchase accounting guidance. We recorded goodwill, primarily related to the expected synergies from combining operations and the value of the existing workforce. We also recorded intangible assets primarily related to customer relationships, developed technology, trademarks, and a covenant not to compete. As of the filing date of this Form 10-Q, the final purchase accounting and purchase price allocation for the DeWAL acquisition are substantially complete; however, we continue to refine our preliminary valuation of certain acquired assets such as intangible assets and goodwill. The following table represents the preliminary fair values assigned to the acquired assets and liabilities in the transaction:
The intangible assets consist of customer relationships valued at $46.7 million, developed technology valued at $22.0 million, trademarks valued at $4.3 million, and a covenant not to compete valued at $0.5 million. The fair value of acquired identified intangible assets was determined by applying the income approach, using several significant unobservable inputs for projected cash flows and a discount rate. These inputs are considered Level 3 under the fair value measurements and disclosure guidance. The weighted average amortization period for the intangible asset classes are 13.5 years for customer relationships, 8.6 years for developed technology, 5.2 years for trademarks, and 3.8 years for a covenant not to compete, resulting in amortization expenses ranging from $2.4 million to $4.3 million, annually. The future estimated annual amortization expense is $2.2 million for the remainder of 2017, $3.7 million for 2018, $4.1 million for 2019, and $4.3 million for 2020 and 2021. During 2016, we incurred transaction costs of $2.1 million related to this acquisition, which were recorded within selling, general and administrative expenses on the consolidated statements of operations. Pro Forma Financial Information The following unaudited pro forma financial information presents the combined results of operations of Rogers, DSP and DeWAL, as if the DSP acquisition had occurred on January 1, 2016 and the DeWAL acquisition had occurred on January 1, 2015. The unaudited pro forma financial information is not intended to represent or be indicative of our consolidated results of operations that would have been reported had the DSP and DeWAL acquisitions been completed as of January 1, 2016, and January 1, 2015, respectively, and should not be taken as indicative of our future consolidated results of operations.
|
Accumulated Other Comprehensive Income (Loss) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) The changes in accumulated other comprehensive income (loss) by component for the three months ended March 31, 2017 and 2016 were as follows:
(1) Net of taxes of $9,144 and $9,160 as of March 31, 2017 and December 31, 2016, respectively. Net of taxes of $9,860 and $9,879 as of March 31, 2016 and December 31, 2015, respectively. (2) Net of taxes of $65 and $0 as of March 31, 2017 and December 31, 2016, respectively. Net of taxes of $3 and $5 as of March 31, 2016 and December 31, 2015, respectively. (3) Net of taxes of $19 and $1 for the pension plans and postretirement benefits and unrealized gain (loss) on derivatives, respectively. (4) Net of taxes of $14 for the pension plans and postretirement benefits. |
Earnings Per Share |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:
Certain potential options to purchase shares may be excluded from the calculation of diluted weighted-average shares outstanding where their exercise price is greater than the average market price of our capital stock during the relevant reporting period. For the quarter ended March 31, 2017, no shares were excluded. For the quarter ended March 31, 2016, 51,275 shares were excluded. |
Stock-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation | Stock-Based Compensation Equity Compensation Awards Performance-Based Restricted Stock Units As of March 31, 2017, we had performance-based restricted stock awards from 2015, 2016 and 2017 outstanding. These awards generally cliff vest at the end of a three year measurement period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the vesting period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures. Compensation expense is recognized using the straight line method over the vesting period, unless the employee has an accelerated vesting schedule. The 2015 awards have two measurement criteria on which the final payout of each award is based - (i) the three year return on invested capital (ROIC) compared to that of a specified group of peer companies, and (ii) the three year total shareholder return (TSR) on the performance of our capital stock as compared to that of a specified group of peer companies. The 2016 and 2017 awards have one measurement criteria - the three year TSR on the performance of our capital stock as compared to that of a specified group of peer companies. In accordance with the applicable accounting literature, the ROIC measurement criteria of the 2015 awards is considered a performance condition. As such, the fair value of the ROIC portion is determined based on the market value of the underlying stock price at the grant date, with cumulative compensation expense recognized to date being increased or decreased based on changes in the forecasted pay out percentage at the end of each reporting period. The TSR measurement criteria of the awards is considered a market condition. As such, the fair value of this measurement criteria was determined on the date of grant using a Monte Carlo simulation valuation model, with related compensation expense fixed on the grant date and expensed on a straight-line basis over the life of the awards that ultimately vest and with no changes for the final projected payout of the awards. Below were the assumptions used in the Monte Carlo calculation:
Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility. Expected term – We use the vesting period of the award to determine the expected term assumption for the Monte Carlo simulation valuation model. Risk-free interest rate – We use an implied “spot rate” yield on U.S. Treasury Constant Maturity rates as of the grant date for our assumption of the risk-free interest rate. Expected dividend yield – We do not currently pay dividends on our capital stock; therefore, a dividend yield of 0% was used in the Monte Carlo simulation valuation model. Forfeiture Rate - We previously estimated the forfeiture rate based on historical experience and our expectations regarding future terminations. To the extent our actual forfeiture rate was different from our estimate, stock-based compensation expense was adjusted accordingly. In accordance with the adoption of ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, on January 1, 2017, we now account for forfeitures as they occur. The adoption of this standard, with respect to treatment of forfeitures, did not have a material impact on our condensed consolidated financial statements. The following table summarizes the change in number of non-vested performance-based restricted stock awards outstanding since March 31, 2017:
During the three months ended March 31, 2017 and March 31, 2016, we recognized compensation income for performance-based stock awards of approximately $0.1 million and expense of approximately $0.7 million respectively. Time-Based Restricted Stock As of March 31, 2017, we had time-based restricted stock grants from 2013, 2014, 2015, 2016 and 2017 outstanding. The only remaining 2013 grant cliff vests on the fourth anniversary of the original grant date. The 2014, 2015, 2016 and 2017 grants all ratably vest on the first, second and third anniversaries of the original grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. The fair value of the award is determined based on the market value of the underlying stock price at the grant date. The following table summarizes the change in number of non-vested time-based restricted stock awards outstanding since March 31, 2017:
During the three months ended March 31, 2017 and 2016 we recognized compensation expense for time-based restricted stock awards of approximately $1.0 million and $1.2 million, respectively. Forfeiture Rate - We previously estimated the forfeiture rate based on historical experience and our expectations regarding future terminations. To the extent our actual forfeiture rate was different from our estimate, stock-based compensation expense was adjusted accordingly. In accordance with the adoption of ASU 2016-09 on January 1, 2017, we now account for forfeitures as they occur. The adoption of this standard, with respect to treatment of forfeitures, did not have a material impact on our condensed consolidated financial statements. Deferred Stock Units We grant deferred stock units to non-management directors. These awards are fully vested on the date of grant and the related shares are generally issued on the 13 month anniversary of the grant date unless the individual elects to defer the receipt of those shares. Each deferred stock unit results in the issuance of one share of Rogers’ stock. The grant of deferred stock units is typically done annually during the second quarter of each year. The fair value of the award is determined based on the market value of the underlying stock price at the grant date. The following table summarizes the change in number of deferred stock units outstanding since March 31, 2017:
There was no expense associated with the deferred stock units in the first quarter of 2017 or 2016. Stock Options Stock options have been granted under various equity compensation plans, and we have generally granted options to employees that vest and become exercisable in one-third increments on the second, third and fourth anniversaries of the grant dates. The maximum contractual term for all options was normally ten years. We used the Black-Scholes option-pricing model to calculate the grant-date fair value of an option. We have not granted any stock options since the first quarter of 2012. The first quarter of 2016 was the final quarter in which we recognized stock based compensation expense related to previously issued stock option grants, and the amount of such expense was de minimis. A summary of the activity under our stock option plans as of March 31, 2017 and changes during the three months then ended, is presented below:
During the three months ended March 31, 2017, the total intrinsic value of options exercised (i.e., the difference between the market price at time of exercise and the price paid by the individual to exercise the options) was $1.1 million, and the total amount of cash received from the exercise of these options was $0.8 million. Employee Stock Purchase Plan We have an employee stock purchase plan (ESPP) that allows eligible employees to purchase, through payroll deductions, shares of our capital stock at a discount to fair market value. The ESPP has two six month offering periods each year, the first beginning in January and ending in June and the second beginning in July and ending in December. The ESPP contains a look-back feature that allows the employee to acquire stock at a 15% discount from the underlying market price at the beginning or end of the applicable period, whichever is lower. We recognize compensation expense on this plan ratably over the offering period based on the fair value of the anticipated number of shares that will be issued at the end of each offering period. Compensation expense is adjusted at the end of each offering period for the actual number of shares issued. Fair value is determined based on two factors: (i) the 15% discount on the underlying stock’s market value on the first day of the applicable offering period and (ii) the fair value of the look-back feature determined by using the Black-Scholes model. We recognized approximately $0.1 million of compensation expense associated with the plan in the quarters ended March 31, 2017 and 2016. |
Pension Benefits and Other Postretirement Benefit Plans |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension Benefit and Other Postretirement Benefit Plans | Pension Benefits and Other Postretirement Benefit Plans Components of Net Periodic (Benefit) Cost The components of net periodic (benefit) cost for the periods indicated were:
Employer Contributions In the first three months of 2017 and 2016, we made required contributions of $0.1 million to our qualified defined benefit pension plans and did not make any voluntary contributions. At December 31, 2016 we had met the minimum funding requirements for all of our qualified defined benefit pension plans due to a required contribution of $0.3 million to the pension plan that covers employees at our Bear, Delaware facility. We estimate that we will be required to make a contribution of $0.3 million in 2017. As there is no funding requirement for the non-qualified defined benefit pension plans or the retiree health and life insurance benefit plans, benefit payments made during the year are funded directly by the Company. |
Segment Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | Segment Information Our reporting structure is comprised of the following operating segments: ACS, EMS, PES, and Other. We believe this structure aligns our external reporting presentation with how we currently manage and view our business internally. In November 2016, we acquired DeWAL, a leading manufacturer of polytetrafluoroethylene, ultra-high molecular weight polyethylene films, pressure sensitive tapes and specialty products for the industrial, aerospace, automotive, and electronics markets. In January 2017, we acquired the principal operating assets of DSP, a custom manufacturer of silicone sheet, extrusions, stripping and compounds. We are in the process of integrating both DeWAL and DSP into our EMS segment. The following table sets forth the information about our segments for the periods indicated, inter-segment sales have been eliminated from the net sales data:
|
Joint Ventures |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Joint Ventures | Joint Ventures As of March 31, 2017, we had two joint ventures, each 50% owned, which were accounted for under the equity method of accounting.
We recognized equity income related to the joint ventures of $1.0 million and $0.6 million for the three months ended March 31, 2017, and 2016 respectively. These amounts are included in the condensed consolidated statements of operations. The summarized financial information for the joint ventures for the periods indicated was as follows:
Receivables from and payables to joint ventures arise during the normal course of business from transactions between us and the joint ventures. We had receivables of $1.8 million and $2.4 million as of March 31, 2017 and December 31, 2016, respectively. We had payables of $1.1 million and $1.6 million as of March 31, 2017 and December 31, 2016, respectively. |
Debt |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Debt Disclosure [Abstract] | |
Debt | Debt On June 18, 2015, we entered into a secured five year credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (the “Second Amended Credit Agreement”). The Second Amended Credit Agreement provided (1) a $55.0 million term loan; (2) up to $295.0 million of revolving loans, with sublimits for multicurrency borrowings, letters of credit and swing-line notes; and (3) a $50.0 million expansion feature. Borrowings could be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Second Amended Credit Agreement). The Second Amended Credit Agreement required mandatory quarterly repayment of principal on amounts borrowed under the term loan, and payment in full of outstanding borrowings by June 30, 2020. On February 17, 2017, we entered into a secured five year credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (the “Third Amended Credit Agreement”), which amended and restated the Second Amended Credit Agreement. The Third Amended Credit Agreement refinances the Second Amended Credit Agreement, eliminates the term loan under the Second Amended Credit Agreement, increases the principal amount of the revolving credit facility to up to $450.0 million borrowing capacity, with sublimits for multicurrency borrowings, letters of credit and swing-line notes, and provides an additional $175.0 million accordion feature. Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Third Amended Credit Agreement). Borrowings under the Third Amended Credit Agreement can be made as alternate base rate loans or euro-currency loans. Alternate base rate loans bear interest that includes a base reference rate plus a spread of 37.5 to 75.0 basis points, depending on our leverage ratio. The base reference rate is the greater of the prime rate; federal funds effective rate (or the overnight bank funding rate, if greater) plus 50 basis points; or adjusted 1-month LIBOR plus 100 basis points. Euro-currency loans bear interest based on adjusted LIBOR plus a spread of 137.5 to 175.0 basis points, depending on our leverage ratio. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Third Amended Credit Agreement, the Company is required to pay a quarterly fee of 20 to 30 basis points (based upon our leverage ratio) of the unused amount of the lenders’ commitments under the Third Amended Credit Agreement. The Third Amended Credit Agreement contains customary representations, warranties, covenants, mandatory prepayments and events of default under which the Company’s payment obligations may be accelerated. If an event of default occurs, the lenders may, among other things, terminate their commitments and declare all outstanding borrowings to be immediately due and payable together with accrued interest and fees. The financial covenants include requirements to maintain (1) a leverage ratio of no more than 3.25 to 1.00, subject to an election to increase the maximum leverage ratio to 3.50 to 1.00 for one fiscal year in connection with a permitted acquisition, and (2) an interest coverage ratio of no less than 3.00 to 1.00. All obligations under the Third Amended Credit Agreement are guaranteed by each of the Company’s existing and future material domestic subsidiaries, as defined in the Third Amended Credit Agreement (the “Guarantors”). The obligations are also secured by a Third Amended and Restated Pledge and Security Agreement, dated as of February 17, 2017, entered into by the Company and the Guarantors which grants to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of the non-real estate assets of the Guarantors. These assets include, but are not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries. All revolving loans are due on the maturity date, February 17, 2022 and as of March 31, 2017, we have $241.2 million in outstanding borrowings under our credit facility. We are not required to make any quarterly principal payments under the Third Amended Credit Agreement. At March 31, 2017, we have $2.7 million of outstanding deferred debt issuance costs consisting of $1.6 million related to the term loans under the Second Amended Credit Agreement and $1.1 million related to the Third Amended Credit Agreement. These costs will be amortized over the life of the Third Amended Credit Agreement, which will terminate in February 2022. We incurred amortization expense of $0.1 million in the three months ended March 31, 2017 and 2016 related to these deferred costs. In March 2017, we entered into an interest rate swap to hedge the variable interest rate on $75.0 million of our $450.0 million revolving credit facility. In July 2012, we entered into an interest rate swap to hedge the variable interest rate on our previously outstanding term loan debt. This swap expired as of June 30, 2016. Restriction on Payment of Dividends Our Third Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our leverage ratio does not exceed 2.75 to 1.00. If our leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our leverage ratio did not exceed 2.75 to 1.00 as of March 31, 2017. Capital Lease We have a capital lease obligation related to our manufacturing facility in Eschenbach, Germany. Under the terms of the leasing agreement, we have an option to purchase the property upon the expiration of the lease in 2021 at a price which is the greater of (i) the then-current market value or (ii) the residual book value of the land including the buildings and installations thereon. The total obligation recorded for the lease as of March 31, 2017 is $5.3 million. Depreciation expense related to the capital lease was $0.1 million for the three months ended March 31, 2017 and 2016. Accumulated depreciation at March 31, 2017 and December 31, 2016 was $3.5 million and $3.4 million, respectively. These expenses are included as depreciation expense in cost of sales on our condensed consolidated statements of operations. We also incurred interest expense on the capital lease of $0.1 million for the three months ended March 31, 2017 and 2016. Interest expense related to the debt recorded on the capital lease is included in interest expense on the condensed consolidated statements of operations. |
Goodwill and Intangible Assets |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill The changes in the carrying amount of goodwill for the period ending March 31, 2017, by segment, were as follows:
Intangible Assets
Gross and net carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations. Amortization expense for the three months ended March 31, 2017 and March 31, 2016 was approximately $3.3 million and $2.6 million, respectively. The estimated future amortization expense is $11.3 million, for the remainder of 2017 and $15.1 million, $14.9 million, $11.7 million and $10.9 million for 2018, 2019, 2020 and 2021, respectively. On November 23, 2016, we acquired DeWAL, and on January 6, 2017, we acquired the principal operating assets of DSP. For further detail on the goodwill and intangible assets recorded on the acquisitions, see Note 5 - Acquisitions. The indefinite-lived trademark intangible assets were acquired as part of the acquisition of Curamik. These assets are assessed for impairment annually or if changes in circumstances indicate that the carrying values may not be recoverable. The definite-lived intangible assets are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset. The weighted average amortization period as of March 31, 2017, by intangible asset class, is presented in the table below:
|
Commitments and Contingencies |
3 Months Ended | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies We are currently engaged in the following environmental and legal proceedings: Voluntary Corrective Action Program The Rogers Corporate Headquarters located in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP). As part of this program, we partnered with the Connecticut Department of Energy and Environmental Protection (CT DEEP) to determine the corrective actions to be taken at the site related to contamination issues. We evaluated this matter and completed internal due diligence work related to the site in the fourth quarter of 2015. We recorded an accrual of $3.2 million as of December 31, 2015 for remediation costs expected to be incurred based on the facts and circumstances known to us at that time. During the third quarter of 2016, the CT DEEP approved a change to our remediation plan for the site that will reduce our overall expected costs. Accordingly, we reduced the accrual by $0.9 million as a result of change in the level of remediation that needs to take place. This benefit was recorded as an offset to selling, general, and administrative expenses in the condensed consolidated statement of operations. Remediation activities on the site continue and as of March 31, 2017, the remaining accrual for future remediation efforts was $1.9 million. Superfund Sites We are currently involved as a potentially responsible party (PRP) in one active case involving a waste disposal site, the Chatham Superfund Site. The costs incurred since inception for this claim have been immaterial and have been primarily covered by insurance policies, for both legal and remediation costs. In this matter, we have been assessed a cost sharing percentage of approximately 2% in relation to the range for estimated total cleanup costs of $18.8 million to $29.6 million. We believe we have sufficient insurance coverage to fully cover this liability and have recorded a liability and related insurance receivable of approximately $0.4 million as of March 31, 2017, which approximates our share of the low end of the estimated range. We believe we are a de minimis participant and, as such, have been allocated an insignificant percentage of the total PRP cost sharing responsibility. Based on facts presently known to us, we believe that the potential for the final results of this case having a material adverse effect on our results of operations, financial position or cash flows is remote. This case has been ongoing for many years and we believe that it will continue for the indefinite future. No time frame for completion can be estimated at the present time. PCB Contamination We have been working with CT DEEP and the United States Environmental Protection Agency (EPA), Region I, in connection with certain polychlorinated biphenyl (PCB) contamination at our facility in Woodstock, Connecticut. The issue was originally discovered in the soil at the facility in the late 1990s, which has been remediated. Further contamination was later found in the groundwater beneath the property, which was addressed with the installation of a pump and treat system in 2011. The future costs related to the maintenance of the groundwater pump and treat system now in place at the site are expected to be minimal. We believe that the remaining remediation activity will continue for several more years and no time frame for completion can be estimated at the present time. PCB contamination at this facility was also found in the buildings and courtyards original to the site, in addition to surrounding areas, including an on-site pond. We have completed remediation activities for the buildings and courtyards. We currently have a reserve of $0.2 million for the pond remediation recorded in our condensed consolidated statements of financial position. We believe this reserve will be adequate to cover the remaining remediation work related to the pond contamination based on the information known at this time. However, if additional contamination is found, the cost of the remaining remediation may increase. Asbestos Litigation We, like many other industrial companies, have been named as a defendant in a number of lawsuits filed in courts across the country by persons alleging personal injury from exposure to products containing asbestos. We have never mined, milled, manufactured or marketed asbestos; rather, we made and provided to industrial users a limited number of products that contained encapsulated asbestos, but we stopped manufacturing these products in the late 1980s. Most of the claims filed against us involve numerous defendants, sometimes as many as several hundred. The following table presents information about our recent asbestos claims activity:
For the three months ended March 31, 2017, 118 claims were dismissed and 5 claims were settled. Settlements totaled approximately $1.0 million for the three months ended March 31, 2017. We recognize a liability for asbestos-related contingencies that are probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos related matters, we record asbestos-related insurance receivables that are deemed probable. Our estimates of asbestos-related contingent liabilities and related insurance receivables are based on an independent actuarial analysis and an independent insurance usage analysis prepared annually by third parties. The actuarial analysis contains numerous assumptions, including general assumptions regarding the asbestos-related product liability litigation environment and company-specific assumptions regarding claims rates (including diseases alleged), dismissal rates, average settlement costs and average defense costs. The insurance usage analysis considers, among other things, applicable deductibles, retentions and policy limits, the solvency and historical payment experience of various insurance carriers, the likelihood of recovery as estimated by external legal counsel and existing insurance settlements. We review our asbestos-related forecasts annually in the fourth quarter of each year unless facts and circumstances materially change during the year, at which time we would analyze these forecasts. Currently, these analyses project liabilities and related insurance receivables over a 10-year period. It is probable we will incur additional costs for asbestos-related claims following this 10-year period, but we do not believe that any related contingencies are reasonably estimable beyond such period based on, among other things, the significant proportion of future claims included in the analysis and the lag time between the date a claim is filed and its resolution. Accordingly, no liability (or related asset) has yet been recorded for claims that may be asserted subsequent to 2025. As of December 31, 2016, the asbestos-related claims and insurance receivables for the 10-year projection period were $52.0 million and $48.4 million, respectively. As of March 31, 2017, there have been no changes to these projections. To date, the defense and settlement costs of our asbestos-related product liability litigation have been substantially covered by insurance. We have identified continuous coverage for primary, excess and umbrella insurance from the 1950s through the mid-1980s, except for a period in the early 1960s, with respect to which we have entered into an agreement for primary, but not excess or umbrella, coverage. In addition, we have entered into a cost sharing agreement with most of our primary, excess and umbrella insurance carriers to facilitate the ongoing administration and payment of claims by the carriers. The cost sharing agreement may be terminated by any party, but will continue until a party elects to terminate it. As of the filing date for this report, the agreement has not been terminated. As previously disclosed, however, we expect to exhaust individual primary, excess and umbrella coverages over time, and there is no assurance that such exhaustion will not accelerate due to additional claims, damages and settlements or that coverage will be available as expected. Accordingly, while we believe it is reasonably possible that we may incur losses and defense costs in excess of our accruals in the future, we do not have sufficient data to provide a reasonable estimate or range of such losses and defense costs, at this time. The amounts recorded for the asbestos-related liability and the related insurance receivables described above were based on facts known at the time and a number of assumptions. However, projecting future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded. There can be no assurance that our accrued asbestos liabilities will approximate our actual asbestos-related settlement and defense costs, or that our accrued insurance recoveries will be realized. We will continue to vigorously defend ourselves and believe we have substantial unutilized insurance coverage to mitigate future costs related to this matter. General Litigation In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies. Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business. We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation, after taking into account insurance coverage and the aforementioned accruals, will have a material adverse impact on our results of operations, financial position or cash flows. |
Share Repurchase |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Equity [Abstract] | |
Share Repurchase | Share Repurchase On August 6, 2015, we initiated a share repurchase program (the Program) of up to $100.0 million of the Company’s capital stock. We initiated the Program to mitigate potentially dilutive effects of stock options and shares of restricted stock granted by the Company, in addition to enhancing shareholder value. The Program has no expiration date, and may be suspended or discontinued at any time without notice. As of March 31, 2017, $52.0 million remained available to repurchase under the Program. No shares of capital stock were repurchased during the three months ended March 31, 2017. All previous repurchases were made using cash from operations and cash on hand. |
Income Taxes |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Our effective income tax rate was 32.3% and 35.2% for the three months ended March 31, 2017 and 2016, respectively. The decrease from the first quarter of 2016 is primarily due to excess tax deductions on stock based compensation recognized in 2017, a change in the mix of pretax earnings and a decrease in accruals for uncertain tax positions, partially offset by accruals for distribution taxes on current year earnings in our Chinese subsidiaries that are not considered permanently reinvested. The total amount of unrecognized tax benefits as of March 31, 2017 was $6.3 million, of which $6.1 million would affect our effective tax rate if recognized. It is reasonably possible that approximately $1.5 million of our unrecognized tax benefits as of March 31, 2017 will reverse within the next twelve months. We recognize interest and penalties related to unrecognized tax benefits through income tax expense. As of March 31, 2017, we had $0.5 million accrued for the payment of interest. We are subject to taxation in the U.S. and various state and foreign jurisdictions. With few exceptions, we are no longer subject to examinations by tax authorities for years prior to 2012. The Company adopted ASU 2016-09 on January 1, 2017. Upon adoption, the Company recognized excess tax benefits of approximately $12.7 million in deferred tax assets that were previously not recognized in a cumulative-effect adjustment to retained earnings. In addition, the new guidance requires that all of the tax effects related to share-based payments at settlement or expiration be recorded through the statement of operations which resulted in $1.1 million of income tax benefits during the quarter. See Note 19 - “Recent Accounting Standards” for further information. |
Restructuring |
3 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||
Restructuring | Restructuring On August 8, 2016, we announced our intention to relocate our global headquarters from Rogers, Connecticut to Chandler, Arizona. The move will build upon our presence in Arizona, where we already have major business and manufacturing operations. The decision supports our long-term strategy and is an integral part of our plans for growth and expansion. The new corporate headquarters location will be home to approximately 70 employees who support areas such as human resources, information technology, finance and supply chain, among others. The Rogers, Connecticut location will continue to have manufacturing, research and development and support services. In the first quarter of 2017, we recorded $0.7 million of expense related to this project.
The fair value of the total severance benefits to be paid is $1.2 million, of this, $0.2 million was expensed in the first quarter of 2017. This total will be expensed ratably over the required service period for the affected employees. |
Assets Held for Sale |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Assets Held-for-sale, Not Part of Disposal Group [Abstract] | |
Assets Held for Sale | Assets Held for Sale In the first quarter of 2017, we completed the planned sale of a parcel of land in Belgium that had been classified as held for sale as of December 31, 2016. We recognized a gain on sale of approximately $0.9 million during the quarter in operating income. We also began actively marketing for sale a facility in Belgium with a net book value of $1.7 million. The asset is classified as held for sale as of March 31, 2017 and is no longer being depreciated. As the facility is expected to be sold within the next twelve months, the asset has been classified as current. |
Recent Accounting Standards |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Recent Accounting Standards | Recent Accounting Standards In March 2017, the FASB issued ASU No. 2017-05 and ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Post-Retirement Benefit Cost. The changes to the standard require employers to report the service cost component in the same line item as other compensation costs arising from services rendered by employees during the reporting period. The other components of net benefit costs will be presented in the statement of operations separately from the service cost and outside of a subtotal of operating income from operations. In addition, only the service cost component may be eligible for capitalization where applicable. ASU No. 2017-05 and ASU 2017-07 are effective for annual periods beginning after December 15, 2017. The Company expects to adopt this guidance when effective and the adoption is not expected to have a material effect on the financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, in an effort to simplify the subsequent measurement of goodwill and the associated procedures to determine fair value. The amendments of this ASU are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, however, the Company has not yet determined if it will adopt prior to 2020. The adoption of this guidance is not expected to have a material impact on our financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, with the intention to reduce diversity in practice, as well as simplify elements of classification within the statement of cash flows for certain transactions. The update was effective for interim and annual reporting periods beginning after December 15, 2016. The accounting update was to be adopted using a retrospective approach. We adopted ASU 2016-15 effective January 1, 2017, and it did not have a material impact on our financial statements. In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting, which contains amendments intended to simplify various aspects of share-based payment accounting and presentation in the financial statements, including the income tax consequences, classification of awards as either equity or liabilities, treatment of forfeitures and statutory tax withholding requirements, and classification in the statement of cash flows. The update was effective for interim and annual reporting periods beginning after December 15, 2016. The new standard required a modified retrospective transition through a cumulative effect adjustment as of the beginning of the period of adoption, with certain provisions requiring either a prospective or retrospective transition. The Company adopted ASU 2016-09 on January 1, 2017. Upon adoption, the Company recognized excess tax benefits of approximately $12.7 million in deferred tax assets that were previously not recognized in a cumulative-effect adjustment to retained earnings. In addition, the new guidance requires that all of the tax effects related to share-based payments at settlement or expiration be recorded through the statement of operations. The Company also adopted the standard with respect to treatment of forfeitures, which did not have a material impact on our financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on whether the lease effectively finances a purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method (finance lease) or on a straight line basis over the term of the lease (operating lease). A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU No. 2016-2 supersedes the existing guidance on accounting for leases. The standard is effective for interim and annual reporting periods for fiscal years beginning after December 15, 2018. Early adoption of this standard is permitted and it is to be adopted using a modified retrospective approach. We have initiated our implementation plan, which includes ensuring appropriate classification of our lease agreements and quantifying the accounting impact in accordance with the new accounting standard. We expect to adopt this accounting standard beginning in fiscal year 2019. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the agreed upon delay, the updated standard is effective for us beginning in the first quarter of 2018. Early adoption is permitted, but not before the original effective date of the standard. During 2016, the FASB issued new accounting standards updates regarding principal versus agent considerations in determining revenue recognition identifying performance obligations and licensing, collectability, sales tax, non-cash considerations, completed contracts, contract modifications and effect of accounting change. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We plan to adopt this standard using the modified retrospective approach, however, we will continue to evaluate our options as the implementation process continues. We have established a cross-functional coordinated implementation team and engaged a third party service provider to assist with the evaluation. We are in the process of identifying, evaluating and implementing changes to our systems, processes and internal controls, as necessary, to meet the reporting and disclosure requirements. We are still in the process of evaluating our contracts, and at this stage of the process, we have not yet determined if the adoption of the new standard will have a material impact on the amount or timing of net sales, and we continue to evaluate the impact of the new standard on our consolidated financial statements and disclosures. |
Recent Accounting Standards (Policies) |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Accounting Policies [Abstract] | |
Recent Accounting Standards | Recent Accounting Standards In March 2017, the FASB issued ASU No. 2017-05 and ASU No. 2017-07, Compensation - Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Post-Retirement Benefit Cost. The changes to the standard require employers to report the service cost component in the same line item as other compensation costs arising from services rendered by employees during the reporting period. The other components of net benefit costs will be presented in the statement of operations separately from the service cost and outside of a subtotal of operating income from operations. In addition, only the service cost component may be eligible for capitalization where applicable. ASU No. 2017-05 and ASU 2017-07 are effective for annual periods beginning after December 15, 2017. The Company expects to adopt this guidance when effective and the adoption is not expected to have a material effect on the financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, in an effort to simplify the subsequent measurement of goodwill and the associated procedures to determine fair value. The amendments of this ASU are effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, however, the Company has not yet determined if it will adopt prior to 2020. The adoption of this guidance is not expected to have a material impact on our financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, with the intention to reduce diversity in practice, as well as simplify elements of classification within the statement of cash flows for certain transactions. The update was effective for interim and annual reporting periods beginning after December 15, 2016. The accounting update was to be adopted using a retrospective approach. We adopted ASU 2016-15 effective January 1, 2017, and it did not have a material impact on our financial statements. In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting, which contains amendments intended to simplify various aspects of share-based payment accounting and presentation in the financial statements, including the income tax consequences, classification of awards as either equity or liabilities, treatment of forfeitures and statutory tax withholding requirements, and classification in the statement of cash flows. The update was effective for interim and annual reporting periods beginning after December 15, 2016. The new standard required a modified retrospective transition through a cumulative effect adjustment as of the beginning of the period of adoption, with certain provisions requiring either a prospective or retrospective transition. The Company adopted ASU 2016-09 on January 1, 2017. Upon adoption, the Company recognized excess tax benefits of approximately $12.7 million in deferred tax assets that were previously not recognized in a cumulative-effect adjustment to retained earnings. In addition, the new guidance requires that all of the tax effects related to share-based payments at settlement or expiration be recorded through the statement of operations. The Company also adopted the standard with respect to treatment of forfeitures, which did not have a material impact on our financial statements. In February 2016, the FASB issued ASU No. 2016-02, Leases, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on whether the lease effectively finances a purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method (finance lease) or on a straight line basis over the term of the lease (operating lease). A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. ASU No. 2016-2 supersedes the existing guidance on accounting for leases. The standard is effective for interim and annual reporting periods for fiscal years beginning after December 15, 2018. Early adoption of this standard is permitted and it is to be adopted using a modified retrospective approach. We have initiated our implementation plan, which includes ensuring appropriate classification of our lease agreements and quantifying the accounting impact in accordance with the new accounting standard. We expect to adopt this accounting standard beginning in fiscal year 2019. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the agreed upon delay, the updated standard is effective for us beginning in the first quarter of 2018. Early adoption is permitted, but not before the original effective date of the standard. During 2016, the FASB issued new accounting standards updates regarding principal versus agent considerations in determining revenue recognition identifying performance obligations and licensing, collectability, sales tax, non-cash considerations, completed contracts, contract modifications and effect of accounting change. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We plan to adopt this standard using the modified retrospective approach, however, we will continue to evaluate our options as the implementation process continues. We have established a cross-functional coordinated implementation team and engaged a third party service provider to assist with the evaluation. We are in the process of identifying, evaluating and implementing changes to our systems, processes and internal controls, as necessary, to meet the reporting and disclosure requirements. We are still in the process of evaluating our contracts, and at this stage of the process, we have not yet determined if the adoption of the new standard will have a material impact on the amount or timing of net sales, and we continue to evaluate the impact of the new standard on our consolidated financial statements and disclosures. |
Fair Value Measurements (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets Measured at Fair Value on a Recurring Basis, Categorized by the Level of Inputs Used in the Valuation | From time to time we enter into various instruments that require fair value measurement. Assets and liabilities measured on a recurring basis, categorized by the level of inputs used in the valuation, included:
|
Hedging Transactions and Derivative Financial Instruments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Notional Amounts of Outstanding Derivative Positions | As of March 31, 2017 the notional values of these foreign currency forward contracts were:
The notional values of our copper contracts outstanding as of March 31, 2017 were:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | Effects on Statements of Operations and of Comprehensive Income (Loss):
|
Inventories (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | Inventories were as follows at the end of the periods noted below:
|
Acquisitions (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of assets acquired and liabilities assumed | The following table represents the preliminary fair market values assigned to the acquired assets and liabilities in the transaction:
The following table represents the preliminary fair values assigned to the acquired assets and liabilities in the transaction:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business acquisition, pro forma information | The following unaudited pro forma financial information presents the combined results of operations of Rogers, DSP and DeWAL, as if the DSP acquisition had occurred on January 1, 2016 and the DeWAL acquisition had occurred on January 1, 2015. The unaudited pro forma financial information is not intended to represent or be indicative of our consolidated results of operations that would have been reported had the DSP and DeWAL acquisitions been completed as of January 1, 2016, and January 1, 2015, respectively, and should not be taken as indicative of our future consolidated results of operations.
|
Accumulated Other Comprehensive Income (Loss) (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Balances Related to Each Component of Accumulated Other Comprehensive Income (Loss) | The changes in accumulated other comprehensive income (loss) by component for the three months ended March 31, 2017 and 2016 were as follows:
(1) Net of taxes of $9,144 and $9,160 as of March 31, 2017 and December 31, 2016, respectively. Net of taxes of $9,860 and $9,879 as of March 31, 2016 and December 31, 2015, respectively. (2) Net of taxes of $65 and $0 as of March 31, 2017 and December 31, 2016, respectively. Net of taxes of $3 and $5 as of March 31, 2016 and December 31, 2015, respectively. (3) Net of taxes of $19 and $1 for the pension plans and postretirement benefits and unrealized gain (loss) on derivatives, respectively. (4) Net of taxes of $14 for the pension plans and postretirement benefits. |
Earnings Per Share (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Computation of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share, for the periods indicated:
|
Stock-Based Compensation (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assumptions Used in Calculation of Fair Value | Below were the assumptions used in the Monte Carlo calculation:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Activity Under Stock Option Plans | A summary of the activity under our stock option plans as of March 31, 2017 and changes during the three months then ended, is presented below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Time Based Restricted Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Activities | The following table summarizes the change in number of non-vested time-based restricted stock awards outstanding since March 31, 2017:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Performance-Based Restricted Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Activities | The following table summarizes the change in number of non-vested performance-based restricted stock awards outstanding since March 31, 2017:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Stock Units | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restricted Stock Activities | The following table summarizes the change in number of deferred stock units outstanding since March 31, 2017:
|
Pension Benefits and Other Postretirement Benefit Plans (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of net periodic benefit cost | The components of net periodic (benefit) cost for the periods indicated were:
|
Segment Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reportable Segment Information | The following table sets forth the information about our segments for the periods indicated, inter-segment sales have been eliminated from the net sales data:
|
Joint Ventures (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Joint Ventures Accounted for Under Equity Method of Accounting | As of March 31, 2017, we had two joint ventures, each 50% owned, which were accounted for under the equity method of accounting.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summarized Information for Joint Ventures | The summarized financial information for the joint ventures for the periods indicated was as follows:
|
Goodwill and Intangible Assets (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill | The changes in the carrying amount of goodwill for the period ending March 31, 2017, by segment, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets | Intangible Assets
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted Average Amortization Period, by Intangible Asset Class | The weighted average amortization period as of March 31, 2017, by intangible asset class, is presented in the table below:
|
Commitments and Contingencies (Tables) |
3 Months Ended | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | ||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | The following table presents information about our recent asbestos claims activity:
|
Restructuring (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2017 | |||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||
Restructuring and Related Costs |
|
Hedging Transactions and Derivative Financial Instruments (Additional Information) (Details) |
Mar. 31, 2017
USD ($)
Contract
|
Feb. 17, 2017
USD ($)
|
---|---|---|
Bank Term Loan | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Number of derivative contracts related to minimizing risk associated with potential rise in copper prices (contract) | Contract | 24 | |
Third Amended Credit Agreement | Revolving Credit Facility | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Maximum borrowing capacity | $ 450,000,000.0 | |
Interest rate swap | Third Amended Credit Agreement | Revolving Credit Facility | ||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||
Hedged balance on debt instrument | $ 75,000,000 |
Hedging Transactions and Derivative Financial Instruments (Effect and Fair Value of Derivative Instruments) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Contracts not designated as hedging instruments | Other income (expense), net | Foreign Exchange Contracts | ||
Derivative [Line Items] | ||
Effect of current derivative instruments | $ 0 | $ (114) |
Fair Values of Derivative Instruments | 21 | (114) |
Contracts not designated as hedging instruments | Other income (expense), net | Copper Derivatives | ||
Derivative [Line Items] | ||
Effect of current derivative instruments | 215 | 33 |
Fair Values of Derivative Instruments | 1,342 | 255 |
Contracts designated as hedging instruments | Other comprehensive income (loss) | Interest Rate Swap | ||
Derivative [Line Items] | ||
Effect of current derivative instruments | (180) | 11 |
Fair Values of Derivative Instruments | $ (180) | $ (7) |
Inventories (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Inventory Disclosure [Abstract] | ||
Raw materials | $ 33,850 | $ 29,788 |
Work-in-process | 26,452 | 26,440 |
Finished goods | 34,493 | 34,902 |
Total inventories | $ 94,795 | $ 91,130 |
Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Jan. 06, 2017 |
Dec. 31, 2016 |
Nov. 23, 2016 |
---|---|---|---|---|
Assets: | ||||
Goodwill | $ 228,229 | $ 208,431 | ||
DeWAL Industries LLC. | ||||
Assets: | ||||
Cash and cash equivalents | $ 1,539 | |||
Accounts receivable | 7,513 | |||
Other current assets | 691 | |||
Inventory | 9,915 | |||
Property, plant & equipment | 9,932 | |||
Intangible assets | 73,500 | |||
Goodwill | 35,755 | |||
Other long-term assets | 101 | |||
Total assets | 138,946 | |||
Liabilities: | ||||
Accounts payable | 2,402 | |||
Other current liabilities | 1,062 | |||
Total liabilities | 3,464 | |||
Fair value of net assets acquired | $ 135,482 | |||
Diversified Silicone Products, Inc. | ||||
Assets: | ||||
Accounts receivable | $ 2,724 | |||
Prepaid expenses | 21 | |||
Inventory | 2,433 | |||
Property, plant & equipment | 1,589 | |||
Intangible assets | 35,860 | |||
Goodwill | 17,793 | |||
Total assets | 60,420 | |||
Liabilities: | ||||
Accounts payable | 179 | |||
Accrued expenses | 50 | |||
Total liabilities | 229 | |||
Fair value of net assets acquired | $ 60,191 |
Acquisitions - Business Acquisition Pro Forma Information (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Business Combinations [Abstract] | |
Net sales | $ 178,897 |
Net income | $ 13,263 |
Earnings Per Share (Computation of Basic and Diluted) (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Numerator: | ||
Net income | $ 27,032 | $ 14,928 |
Denominator: | ||
Weighted-average shares outstanding - basic (shares) | 18,056,000 | 17,966,000 |
Effect of dilutive shares (shares) | 317,000 | 248,000 |
Weighted-average shares outstanding - diluted (shares) | 18,373,000 | 18,214,000 |
Basic earnings per share (in dollars per share) | $ 1.50 | $ 0.83 |
Diluted earnings per share (in dollars per share) | $ 1.47 | $ 0.82 |
Anti-dilutive shares excluded (shares) | 0 | 51,275 |
Stock-Based Compensation (Additional Information) (Details) $ in Millions |
3 Months Ended | 60 Months Ended | |
---|---|---|---|
Mar. 31, 2017
USD ($)
offering_periods
|
Mar. 31, 2016
USD ($)
|
Mar. 31, 2017
shares
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Cash received from exercise of stock options | $ 0.8 | ||
Employee Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Stock options, contractual term (years) | 10 years | ||
Stock options, grants in period, gross | shares | 0 | ||
Options exercised, total intrinsic value | $ 1.1 | ||
Performance-Based Restricted Stock | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Restricted stock award program, measurement period (years) | 3 years | ||
Expected dividend yield (percent) | 0.00% | ||
Compensation expense (income) | $ (0.1) | $ 0.7 | |
Performance-Based Restricted Stock | Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Restricted stock award program, awarded shares as a percentage of the original award amount (percent) | 0.00% | ||
Performance-Based Restricted Stock | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Restricted stock award program, awarded shares as a percentage of the original award amount (percent) | 200.00% | ||
Time Based Restricted Stock | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation expense (income) | $ 1.0 | 1.2 | |
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Compensation expense (income) | $ 0.1 | $ 0.1 | |
Employee stock purchase plan, number of offering (offering period) | offering_periods | 2 | ||
Employee stock purchase plan, offering period (months) | 6 months | ||
Employee stock purchase plan, purchase price discount (percent) | 15.00% |
Stock-Based Compensation (Monte Carlo Calculation Assumptions) (Details) - Performance-Based Restricted Stock |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected volatility (percent) | 33.60% | 29.60% |
Expected term (years) | 3 years | 3 years |
Risk-free interest rate (percent) | 1.38% | 0.93% |
Stock-Based Compensation (Performance Based Restricted Stock Awards) (Details) - Performance-Based Restricted Stock |
3 Months Ended |
---|---|
Mar. 31, 2017
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Non-vested awards outstanding beginning balance (shares) | 151,769 |
Awards granted (shares) | 56,147 |
Stock issued (shares) | (33,887) |
Awards forfeited (shares) | (3,205) |
Non-vested awards outstanding ending balance (shares) | 170,824 |
Stock-Based Compensation (Time Based Restricted Stock Awards) (Details) - Time Based Restricted Stock |
3 Months Ended |
---|---|
Mar. 31, 2017
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Non-vested awards outstanding beginning balance (shares) | 239,189 |
Awards granted (shares) | 75,710 |
Stock issued (shares) | (67,183) |
Awards forfeited (shares) | (4,385) |
Non-vested awards outstanding ending balance (shares) | 243,331 |
Stock-Based Compensation (Deferred Stock Units) (Details) - Deferred Stock Units |
3 Months Ended |
---|---|
Mar. 31, 2017
shares
| |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Conversion ratio | 1 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | |
Non-vested awards outstanding beginning balance (shares) | 11,900 |
Awards granted (shares) | 0 |
Stock issued (shares) | 0 |
Non-vested awards outstanding ending balance (shares) | 11,900 |
Stock-Based Compensation (Summary of Activity Under Stock Option Plans) (Details) - USD ($) |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2017 |
Dec. 31, 2016 |
|
Options Outstanding | ||
Options outstanding at December 31, 2016 (shares) | 116,575 | |
Options exercised (shares) | (22,300) | |
Options forfeited (shares) | 0 | |
Options outstanding at March 31, 2017 (shares) | 94,275 | 116,575 |
Options exercisable at March 31, 2017 (shares) | 94,275 | |
Options vested at December 31, 2016 (shares) | 94,275 | |
Weighted- Average Exercise Price Per Share | ||
Options outstanding at December 31, 2016 (in USD per share) | $ 37.76 | |
Options exercised (in USD per share) | 34.30 | |
Options forfeited (dollars per share) | 0.00 | |
Options outstanding at March 31, 2017 (in USD per share) | 37.46 | $ 37.76 |
Options exercisable at March 31, 2017 (in USD per share) | 37.46 | |
Options vested at December 31, 2016 (in USD per share) | $ 37.46 | |
Weighted-Average Remaining Contractual Life in Years | ||
Weighted-Average Remaining Contractual Life in Year, Options outstanding | 3 years 1 month | 3 years 2 months |
Options exercisable, Weighted-Average Remaining Contractual Life in Years (years) | 3 years 1 month | |
Options vested, Weighted-Average Remaining Contractual Life in Years (years) | 3 years 1 month | |
Aggregate Intrinsic Value | ||
Options outstanding, Aggregate Intrinsic Value at December 31, 2016 | $ 4,552,580 | |
Options outstanding, Aggregate Intrinsic Value, at March 31, 2017 | 4,563,655 | $ 4,552,580 |
Options exercisable, Aggregate Intrinsic Value | 4,563,655 | |
Options vested, Aggregate Intrinsic Value | $ 4,563,655 |
Pension Benefits and Other Postretirement Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
|
Pension Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Interest cost | $ 1,841 | $ 1,893 | |
Expected return on plan assets | (2,309) | (2,706) | |
Amortization of net loss (gain) | 433 | 447 | |
Net periodic (benefit) cost | (35) | (366) | |
Retirement Health and Life Insurance Benefits | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Service cost | 39 | 37 | |
Interest cost | 18 | 19 | |
Amortization of prior service cost (credit) | (373) | (373) | |
Amortization of net loss (gain) | (14) | (19) | |
Net periodic (benefit) cost | (330) | (336) | |
Bear Plan | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Defined benefit pension plan, required employer contribution | 100 | $ 100 | |
Defined benefit plan, contributions by employer | $ 300 | ||
Defined benefit plan, estimated future employer contribution | $ 300 |
Segment Information (Income by Reportable Segments) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Segment Reporting Information [Line Items] | ||
Net sales | $ 203,828 | $ 160,566 |
Operating income | 39,441 | 24,099 |
Equity income in unconsolidated joint ventures | 1,009 | 613 |
Other income (expense), net | 715 | (546) |
Interest expense, net | (1,248) | (1,121) |
Income before income tax expense | 39,917 | 23,045 |
Advanced Connectivity Solutions | ||
Segment Reporting Information [Line Items] | ||
Net sales | 78,543 | 73,376 |
Operating income | 19,689 | 15,900 |
Elastomeric Material Solutions | ||
Segment Reporting Information [Line Items] | ||
Net sales | 76,849 | 46,317 |
Operating income | 12,912 | 5,305 |
Power Electronics Solutions | ||
Segment Reporting Information [Line Items] | ||
Net sales | 42,651 | 35,251 |
Operating income | 4,935 | 1,296 |
Other | ||
Segment Reporting Information [Line Items] | ||
Net sales | 5,785 | 5,622 |
Operating income | $ 1,905 | $ 1,598 |
Joint Ventures (Additional Information) (Details) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2017
USD ($)
Entity
|
Mar. 31, 2016
USD ($)
|
Dec. 31, 2016
USD ($)
|
|
Schedule of Equity Method Investments [Line Items] | |||
Number of joint ventures that are 50% owned (entity) | Entity | 2 | ||
Equity income related to joint ventures | $ 1,009 | $ 613 | |
Due from joint ventures, current | $ 1,800 | $ 2,400 | |
Rogers INOAC Corporation (RIC) | |||
Schedule of Equity Method Investments [Line Items] | |||
Ownership interest in joint venture (percent) | 50.00% | ||
Rogers INOAC Suzhou Corporation (RIS) | |||
Schedule of Equity Method Investments [Line Items] | |||
Ownership interest in joint venture (percent) | 50.00% | ||
Corporate Joint Venture | |||
Schedule of Equity Method Investments [Line Items] | |||
Due to related parties, current | $ 1,100 | $ 1,600 |
Joint Ventures (Accounted for Under Equity Method of Accounting) (Details) |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Schedule of Equity Method Investments [Line Items] | |
Fiscal Year-End | --12-31 |
Rogers INOAC Corporation (RIC) | Japan | High Performance Foams | |
Schedule of Equity Method Investments [Line Items] | |
Fiscal Year-End | --10-31 |
Rogers INOAC Suzhou Corporation (RIS) | China | High Performance Foams | |
Schedule of Equity Method Investments [Line Items] | |
Fiscal Year-End | --12-31 |
Joint Ventures (Summarized Information for Joint Ventures) (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Equity Method Investments and Joint Ventures [Abstract] | ||
Net sales | $ 11,185 | $ 9,237 |
Gross profit | 4,311 | 3,099 |
Net income | $ 2,018 | $ 1,226 |
Debt (Additional Information) (Details) |
3 Months Ended | ||||
---|---|---|---|---|---|
Jun. 18, 2015
USD ($)
|
Mar. 31, 2017
USD ($)
|
Mar. 31, 2016
USD ($)
|
Feb. 17, 2017
USD ($)
|
Dec. 31, 2016
USD ($)
|
|
Debt Instrument [Line Items] | |||||
Debt issuance cost | $ 2,700,000 | ||||
Amortization expense, debt issue costs | $ 100,000 | $ 100,000 | |||
Debt instrument, leverage ratio, maximum | 2.75 | ||||
Capital lease, expiration date | 2021 | ||||
Capital lease obligation | $ 5,300,000 | ||||
Amortization expense related to the capital lease | 100,000 | 100,000 | |||
Capital lease accumulated depreciation | 3,500,000 | $ 3,400,000 | |||
Interest expense on capital lease | 100,000 | $ 100,000 | |||
Maximum | |||||
Debt Instrument [Line Items] | |||||
Dividends | 20,000,000 | ||||
Credit Agreement | |||||
Debt Instrument [Line Items] | |||||
Variable rate lower range basis spread | 37.50% | ||||
Variable rate higher range basis spread | 75.00% | ||||
Line of credit, base reference rate description | The base reference rate is the greater of the prime rate; federal funds effective rate (or the overnight bank funding rate, if greater) plus 50 basis points; or adjusted 1-month LIBOR plus 100 basis points. | ||||
Amended Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Credit agreement, agreement period (in years) | 5 years | ||||
Expansion option | $ 50,000,000 | ||||
Debt issuance cost | 1,600,000 | ||||
Amended Credit Facility | Federal Funds Effective Swap Rate | |||||
Debt Instrument [Line Items] | |||||
Variable rate lower range basis spread | 0.50% | ||||
Amended Credit Facility | LIBOR | |||||
Debt Instrument [Line Items] | |||||
Variable rate higher range basis spread | 1.00% | ||||
Amended Credit Facility | Bank Term Loan | |||||
Debt Instrument [Line Items] | |||||
Maximum borrowing capacity | $ 55,000,000 | ||||
Amended Credit Facility | Revolving Credit Facility | |||||
Debt Instrument [Line Items] | |||||
Maximum borrowing capacity | $ 295,000,000 | ||||
Third Amended Credit Agreement | |||||
Debt Instrument [Line Items] | |||||
Leverage ratio | 3.25 | ||||
One-time leverage ratio maximum option | 3.50 | ||||
ICR covenant limit | 3.00 | ||||
Debt issuance cost | 1,100,000 | ||||
Eurocurrency loans | Credit Agreement | |||||
Debt Instrument [Line Items] | |||||
Line of credit, LIBOR rate, minimum spread | 137.50% | ||||
Line of credit, LIBOR rate, maximum spread | 175.00% | ||||
Revolving Credit Facility | Third Amended Credit Agreement | |||||
Debt Instrument [Line Items] | |||||
Maximum borrowing capacity | $ 450,000,000.0 | ||||
Additional borrowing capacity | $ 175,000,000 | ||||
Outstanding borrowings | $ 241,200,000 | ||||
Revolving Credit Facility | Third Amended Credit Agreement | Minimum | |||||
Debt Instrument [Line Items] | |||||
Unused capacity, commitment fee percentage | 20.00% | ||||
Revolving Credit Facility | Third Amended Credit Agreement | Maximum | |||||
Debt Instrument [Line Items] | |||||
Unused capacity, commitment fee percentage | 30.00% |
Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill by Segment) (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Goodwill [Roll Forward] | |
December 31, 2016 | $ 208,431 |
Foreign currency translation adjustment | 1,889 |
Purchase accounting adjustment | 116 |
DSP acquisition | 17,793 |
March 31, 2017 | 228,229 |
Advanced Connectivity Solutions | |
Goodwill [Roll Forward] | |
December 31, 2016 | 51,693 |
Foreign currency translation adjustment | 1,143 |
Purchase accounting adjustment | 116 |
DSP acquisition | 17,793 |
March 31, 2017 | 51,693 |
Elastomeric Material Solutions | |
Goodwill [Roll Forward] | |
December 31, 2016 | 91,531 |
Foreign currency translation adjustment | 0 |
Purchase accounting adjustment | 0 |
DSP acquisition | 0 |
March 31, 2017 | 110,583 |
Power Electronics Solutions | |
Goodwill [Roll Forward] | |
December 31, 2016 | 62,983 |
Foreign currency translation adjustment | 746 |
Purchase accounting adjustment | 0 |
DSP acquisition | 0 |
March 31, 2017 | 63,729 |
Other | |
Goodwill [Roll Forward] | |
December 31, 2016 | 2,224 |
Foreign currency translation adjustment | 0 |
Purchase accounting adjustment | 0 |
DSP acquisition | 0 |
March 31, 2017 | $ 2,224 |
Goodwill and Intangible Assets (Intangible Assets) (Details) - USD ($) $ in Thousands |
Mar. 31, 2017 |
Dec. 31, 2016 |
---|---|---|
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 210,116 | $ 173,272 |
Accumulated Amortization | 44,754 | 40,764 |
Total intangible Assets, Gross Carrying Amount | 214,333 | 177,440 |
Net Carrying Amount | 165,362 | 132,508 |
Indefinite lived intangible assets | 4,217 | 4,168 |
Total intangible assets, Net Carrying Amount | 169,579 | 136,676 |
Trademarks and patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 10,177 | 6,825 |
Accumulated Amortization | 1,401 | 1,156 |
Net Carrying Amount | 8,776 | 5,669 |
Technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 71,086 | 68,880 |
Accumulated Amortization | 26,217 | 24,365 |
Net Carrying Amount | 44,869 | 44,515 |
Covenant not to compete | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 1,751 | 1,419 |
Accumulated Amortization | 1,009 | 932 |
Net Carrying Amount | 742 | 487 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | 127,102 | 96,148 |
Accumulated Amortization | 16,127 | 14,311 |
Net Carrying Amount | $ 110,975 | $ 81,837 |
Goodwill and Intangible Assets (Additional Information) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense | $ 3.3 | $ 2.6 |
Annual Future Amortization Expense | ||
Anticipated future amortization expense for 2017 | 11.3 | |
Anticipated future amortization expense for 2018 | 15.1 | |
Anticipated future amortization expense for 2019 | 14.9 | |
Anticipated future amortization expense for 2020 | 11.7 | |
Anticipated future amortization expense for 2021 | $ 10.9 |
Goodwill and Intangible Assets (Weighted Average Amortization Period by Intangible Asset Class) (Details) |
3 Months Ended |
---|---|
Mar. 31, 2017 | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Amortization Period (Years) | 8 years 9 months |
Trademarks and patents | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Amortization Period (Years) | 7 years |
Technology | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Amortization Period (Years) | 5 years 9 months |
Customer relationships | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Amortization Period (Years) | 10 years 1 month |
Covenant-not-to-compete | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Weighted Average Amortization Period (Years) | 3 years 4 months |
Commitments and Contingencies (Details) $ in Millions |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2017
USD ($)
claims
LegalMatter
|
Dec. 31, 2016
claims
|
Dec. 31, 2015
USD ($)
|
|
Loss Contingencies [Line Items] | |||
Number of pending claims (legal matter) | claims | 592 | 605 | |
Asbestos forecast claim period | 10 years | 10 years | |
Connecticut Voluntary Corrective Action Program | |||
Loss Contingencies [Line Items] | |||
Estimated total cleanup costs, accrual | $ 1.9 | $ 3.2 | |
Loss contingency accrual, period decrease | (0.9) | ||
Superfund Sites Proceedings | |||
Loss Contingencies [Line Items] | |||
Estimated total cleanup costs, accrual | $ 0.4 | ||
Number of pending claims (legal matter) | LegalMatter | 1 | ||
Estimated total cleanup costs, cost sharing percentage (percent) | 2.00% | ||
PCB Contamination Proceedings | |||
Loss Contingencies [Line Items] | |||
Accrual for environmental loss contingencies | $ 0.2 | ||
Minimum | Superfund Sites Proceedings | |||
Loss Contingencies [Line Items] | |||
Loss contingency, maximum possible loss | 18.8 | ||
Maximum | Superfund Sites Proceedings | |||
Loss Contingencies [Line Items] | |||
Loss contingency, maximum possible loss | $ 29.6 |
Commitments and Contingencies (Schedule of Loss Contingencies) (Details) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2017
USD ($)
claims
| ||||
Liability for Asbestos and Environmental Claims [Roll Forward] | ||||
Claims outstanding at December 31, 2016 | 605 | |||
New claims filed | 110 | |||
Pending claims concluded | (123) | [1] | ||
Claims outstanding at March 31, 2017 | 592 | |||
Number of claims dismissed | 118 | |||
Number of claims settled (claim) | 5 | |||
Claims settlements amount | $ | $ 1.0 | |||
|
Commitments and Contingencies (Schedule of Total Estimated Liability for Asbestos) (Details) $ in Millions |
Dec. 31, 2016
USD ($)
|
---|---|
Commitments and Contingencies Disclosure [Abstract] | |
Asbestos-related claims | $ 52.0 |
Asbestos-related insurance receivables | $ 48.4 |
Share Repurchase (Details) - USD ($) |
3 Months Ended | |
---|---|---|
Mar. 31, 2017 |
Aug. 06, 2015 |
|
Equity [Abstract] | ||
Authorized stock repurchase amount | $ 100,000,000 | |
Remaining authorized stock repurchase amount | $ 52,000,000 | |
Shares of capital stock repurchased (in shares) | 0 |
Income Taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
|
Income Tax Contingency [Line Items] | |||
Effective tax rate (percent) | 32.30% | 35.20% | |
Unrecognized tax benefits | $ 6,300 | ||
Unrecognized tax benefits that would decrease the effective tax rate if recognized | 6,100 | ||
Unrecognized tax benefits that could be recognized within 12 months | 1,500 | ||
Unrecognized tax benefits, penalties accrued | 500 | ||
Stock-based compensation, excess tax benefit, amount | $ 1,100 | ||
Retained Earnings | Accounting Standards Update 2016-09, Excess Tax Benefit Component | |||
Income Tax Contingency [Line Items] | |||
Cumulative effect adjustment | $ 13,000 |
Restructuring - Narrative (Details) $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
employee
| |
Arizona | |
Restructuring Cost and Reserve [Line Items] | |
Number of employees | employee | 70 |
Restructuring charges | $ 700 |
Employee Severance | |
Restructuring Cost and Reserve [Line Items] | |
Restructuring charges | 193 |
Expected cost to be paid | $ 1,200 |
Restructuring - Schedule of Restructuring Costs (Details) - Employee Severance $ in Thousands |
3 Months Ended |
---|---|
Mar. 31, 2017
USD ($)
| |
Restructuring Reserve [Roll Forward] | |
Beginning balance | $ 470 |
Provisions | 193 |
Payments | (238) |
Ending balance | $ 425 |
Assets Held for Sale - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
|
Property, Plant and Equipment [Line Items] | |||
Gain on sale of long-lived asset | $ 942 | $ 0 | |
Assets held for sale | 1,727 | $ 871 | |
Belgium | |||
Property, Plant and Equipment [Line Items] | |||
Gain on sale of long-lived asset | 900 | ||
Assets held for sale | $ 1,727 |
Recent Accounting Pronouncements (Details) $ in Millions |
Dec. 31, 2016
USD ($)
|
---|---|
Retained Earnings | Accounting Standards Update 2016-09, Excess Tax Benefit Component | |
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |
Cumulative effect adjustment | $ 13 |
+^R)WYYX[8FQ)PM[:BV J\C\@-0+2!U[
M;@%<1>$'9%Y YM@W%F!4I$;1C8 D3U8@N1>2.Q!H;Q2/9&6G%%Y$X?JMK;+W
M2%;VRL:+V+C^Q$)X)*D? 2-_145NA,RN*8\F7Z&LU"UT(Q0V!3K?'46K'&_Y
M[B!R.?;VFC39LL:C%8J_AF'L4!"T*1X-6J'X2QVZE8QBZS":-,LU@P5$69[:
M10\61VQ+^,W<1B(XLWMGKL+%Z'SC[9 YHO_*Q^OR*^:WIA/!B4EUT)OC^,J8
M)&I"T9.:2JUNZ+E#R57J9J[:?+RFQHYD_70%@_E_0/4'4$L#!!0 ( )-C
MH4IL%W_-< , T. 8 >&PO=V]R:W-H965T @*ZBQ'-C\
M$>#^_DO,/(MD/,4D=5?5QR&!/%^&8$A@Y!TY %J"D(M; #AS),"Q^U\;G9R]
MVO/YCZS>Y%43O"IMCG'VL+562DN3,[XU7=V:3X)A4,BU;F^YN:^[ &PO=V]R:W-H965T (MG.X[9:'C333^(S=^X> 502P,$% @ DV.A
M2JW="]ZU 0 T@, !D !X;"]W;W)K X!RD#$ ,!2DAM P[+P>8\KE?+ ^I
MW' PS!Q5*+[S $K!-0!/(5OZ1*%(6@H^>F,Y^
M(.83ASNLSZ8R3GL4]ITN7FKOM8SCQP)=C= < &PO=V]R:W-H965TXO4\/D9S,$KB
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M._"DN?M4Q@);TI:1@4[EPO< >!,&ZL+X#4ATV)DO)WPHLRMS@2
M._6^%_&)]R<>>E-%9VI%N@OB7?#>ROV1Y^P6B>:8\Q3#US%+! OL2PJ^E>+,
M_X'S;?AA4^$AP0]_*#QL$V2;!%DBR/Y;XE9,]E<2MNJI!MNF:7*DPL&D25YY
MEX&]Y^E-?H=/T_Y9V%8:1Z[HP\NF_C>('H*4W5T8H2Y\L,50T/AX?!/.=AJS
MR?#8SS^(+=^X_ 502P,$% @ DV.A2MR!Q*"U 0 T@, !D !X;"]W
M;W)K=C,YIZ00Z)] EX2'J
MD$DH5O[,'"MSHT=DIK/O6;CB[9'ZLZE",!Y%W//%6Q^]EI3N;BA+#\A B(XS:L!;T=)Q@,.Q43)S-(MMZ>7VJIYX'!;C^LWH=Z6'+VMWB9
M=R/GJYMN OY*Q:FH6^^12S6*F8'IR+EDBB.Z4T=R5D-WORC94>K75+V+;O+L
M%I(W=JH.^M%^\Q=02P,$% @ DV.A2N4]+P]1 P KPT !D !X;"]W
M;W)K